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Abstract	  BARRIERS	   TO	   REMOTE	   MONITORING	   IN	   PATIENTS	   WITH	   IMPLANTABLE	  CARDIOVERTER	  DEFIBRILLATORS.	  	  	  Elise	   Liu,	   Kristin	   Mattocks,	   Lynda	   Rosenfeld,	   and	   Rachel	   Lampert.	   	   Section	   of	  Cardiology,	   Department	   of	   Internal	  Medicine,	   Yale	   University,	   School	   of	  Medicine,	  New	  Haven,	  CT.	   	  
Background:	   	  Remote	  monitors	  are	  machines	  that	  allow	  patients	  with	  implantable	  cardioverter-­‐defibrillators	   (ICDs)	   to	   transtelephonically	   send	   data	   to	   their	  physicians.	   	   Remote	   monitors	   have	   been	   associated	   with	   increased	   survival	   and	  faster	  recognition	  of	  clinical	  events.	  	  Despite	  the	  benefits	  of	  using	  remote	  monitors,	  they	  are	  highly	  underused.	  	  We	  aimed	  to	  better	  understand	  barriers	  to	  the	  usage	  of	  remote	  monitors.	  	  
Methods:	  	  Mixed	  methods	  interview	  was	  used,	  with	  both	  quantitative	  questions	  and	  qualitative	   in-­‐depth	   interview.	   	   Patients	  who	  had	  Medtronic	   ICDs	   placed	   at	   either	  Yale	   Electrophysiology	   or	   Cardiology	   Associates	   of	   New	   Haven	   were	   invited	   to	  participate.	  	  82	  patients	  consented	  to	  participate.	  
Results:	  Quantitative	  data	  showed	  that	  compared	  to	  people	  who	  do	  not	  use	  remote	  monitors,	   people	  who	   transmit	   are	  more	   likely	   to	   own	   a	   landline,	   use	   computers	  regularly,	  have	  non-­‐government	  health	   insurance,	  and	  believe	   there	   is	  a	  benefit	   to	  using	   the	   monitor.	   	   Qualitative	   data	   showed	   that	   there	   are	   several	   categories	   of	  reasons	   that	   patient	   do	   not	   use	   remote	   monitors	   including	   a	   belief	   that	  transmissions	   are	   being	   sent,	   a	   belief	   that	   there	   is	   no	   benefit	   to	   monitoring,	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problems	   with	   set	   up,	   problems	   with	   phone	   lines,	   financial	   limitations,	   and	   low	  strength	  of	  physician	  recommendation.	  
Conclusions:	   This	   study	   has	   identified	   several	   potential	   barriers	   to	   remote	  monitoring	   that	   should	   be	   confirmed	   with	   quantitative	   methods.	   	   To	   increase	  remote	  monitor	   usage,	   physicians	   ought	   to	   educate	   patients	   about	   the	   benefits	   of	  monitoring	   and	   explicitly	   recommend	   the	   use	   of	   monitors.	   	   In	   addition,	   device	  manufacturers	  should	  provide	  feedback	  from	  monitors	  and	  consider	  ways	  to	  make	  monitoring	  more	  accessible	  to	  patients,	  both	  financially	  and	  technologically.	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I.	  Introduction	  Sudden	  Cardiac	  Death	  Background	  Sudden	  cardiac	  arrest	  is	  defined	  as	  an	  episode	  of	  cessation	  of	  cardiac	  activity	  resulting	   in	   unresponsiveness	   with	   no	   signs	   of	   breathing	   or	   circulation.	   	   Sudden	  cardiac	   arrest	   may	   be	   reversed	   with	   CPR,	   defibrillation,	   or	   cardiac	   pacing.	  	  Alternatively,	  it	  may	  lead	  to	  sudden	  cardiac	  death	  [1].	  	   Sudden	   cardiac	   death	   is	   a	   major	   cause	   of	   death	   in	   the	   United	   States.	  	  Annually,	  roughly	  450,000	  people	  succumb	  to	  sudden	  cardiac	  death.	  [2,	  3]	  Various	  studies	   estimate	   that	   sudden	   cardiac	   death	   causes	   between	   5.6	   percent	   and	   15	  percent	  of	  all	  deaths.	  [3,	  4]	  	  	   Sudden	   cardiac	   death	   can	   affect	   anyone,	   but	   it	   is	   more	   common	   with	  underlying	  heart	  disease,	  male	  gender,	  and	  increasing	  age.	  [5]	  In	  a	  1999	  Center	  for	  Disease	  Control	  and	  Prevention	  (CDC)	  report	  of	  United	  States	  mortality	  data,	  about	  70%	  of	   sudden	   cardiac	  death	   is	   due	   to	  underlying	   coronary	  heart	   disease.	   	   In	   the	  same	   report,	   roughly	   10%	   of	   sudden	   cardiac	   death	   was	   due	   to	   underlying	   non-­‐ischemic	   structural	   heart	   disease,	   such	   as	   myocarditis,	   dilated	   cardiomyopathy,	  hypertrophic	  cardiomyopathy,	  and	  congenital	  abnormalities.	  	  Another	  5%	  of	  sudden	  cardiac	  deaths	  were	  due	  to	  arrhythmias	  without	  underlying	  structural	  disease,	  such	  as	  hereditary	  channelopathies.	   	  Older	  patients	  were	  disproportionately	  affected	  by	  coronary	  heart	  disease,	  and	  patients	  younger	  than	  40	  were	  more	  likely	  to	  have	  non-­‐ischemic	  disease.	  [6]	  	  	   Of	   note,	   the	   presence	   of	   heart	   failure	   increases	   the	   risk	   of	   sudden	   cardiac	  death.	   	  One	  prospective	  cohort	  of	  2,873	  Framingham	  Study	  participants	  found	  that	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having	  heart	   failure	   from	  any	  cause	   increased	  the	  risk	  of	  sudden	  death	  5-­‐fold.	   	   [5]	  On	  a	  similar	  note,	  another	  study	  found	  that	  39%	  of	  deaths	  in	  heart	  failure	  patients	  were	  due	  to	  sudden	  cardiac	  death.	  [7]	  	  Mechanism	  of	  Sudden	  Cardiac	  Death	  Sudden	   cardiac	   death	   is	   most	   often	   due	   to	   ventricular	   fibrillation.	   	   This	   is	  illustrated	   by	   one	   case	   series	   of	   157	   patients	  who	   suffered	   sudden	   cardiac	   death	  while	  wearing	  Holter	  devices,	  which	  allowed	  their	  fatal	  arrhythmias	  to	  be	  analyzed.	  	  In	  this	  study,	  84%	  of	  patients	  had	  a	  tachyarrhythmia	  that	   lead	  to	  their	  death.	   	  The	  vast	   majority	   of	   the	   patients	   dying	   from	   a	   tachyarrythmia	   had	   a	   terminal	   run	   of	  ventricular	   fibrillation,	   preceded	   by	   ventricular	   tachycardia	   (Figure	   1).	   	   The	  remaining	  16%	  of	  patients	  in	  this	  study	  died	  of	  bradyarrhythmias,	  most	  often	  due	  to	  slow	  sinus	  node	  pacing.	  [8]	  	  
Figure	  1.	  	  Rhythm	  strip	  of	  ventricular	  tachycardia	  progressing	  to	  ventricular	  
fibrillation
	  
Ventricular	   fibrillation	   is	   a	   tachyarrhythmia	   that	   results	   in	   uncoordinated	  contraction	   of	   the	   myocardium.	   	   The	   most	   likely	   underlying	   mechanism	   is	   spiral	  waves,	   which	   are	   small,	   three-­‐dimensional	   patterns	   of	   electrical	   activity	   in	   the	  myocardium	  that	   interact	  with	  each	  other	  and	  propagate	   to	   involve	   large	  areas	  of	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the	   heart.	   This	   disorganized	   electrical	   activity	   leads	   to	   uncoordinated,	   fibrillating	  movement	  of	   the	  myocardium,	  which	   is	   seen	  on	  EKG	  as	   irregular	  waveforms	  with	  constantly	  changing	  amplitude	  and	   frequency	  (Figure	  2).	   	  This	   fibrillation	   leads	   to	  cessation	   of	   cardiac	   contraction,	   which	   prevents	   oxygenation	   of	   the	  myocardium.	  	  The	  resulting	  myocardial	   ischemia	  reduces	  excitability	  of	   the	  heart	  and	  over	  a	   few	  minutes	   leads	   to	   longer	   periods	   of	   time	   between	   fibrillation	   waves	   and	   lower	  amplitudes	  of	  waves.	  	  At	  this	  point,	  ventricular	  fibrillation	  becomes	  more	  difficult	  to	  terminate	   than	   at	   the	  onset	   of	   the	   arrhythmia.	   	   The	   fibrillation	  waves	   continue	   to	  become	   finer	   and	   sparser,	   eventually	   leading	   to	   the	   cessation	   of	   observable	  electrical	  activity.	  	  [9],[10]	  	  
	  
Figure	  2.	  Rhythm	  strip	  of	  ventricular	  fibrillation.	  
	  
	  Treatment	  of	  Ventricular	  Fibrillation	  	   Ventricular	   fibrillation	   is	   a	   rapidly	   fatal	   arrhythmia.	   	   In	   the	   past,	   anti-­‐arrhythmic	   drugs	   such	   as	   quinidine	   or	   procainamide	  were	   used	   in	   an	   attempt	   to	  prevent	   ventricular	   fibrillation,	   but	   this	   approach	   was	   not	   very	   effective.	   [11]	   A	  breakthrough	  came	  when	  surgeons	  found	  that	  patients	  who	  developed	  ventricular	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fibrillation	  intraoperatively	  could	  sometimes	  be	  saved	  by	  opening	  up	  the	  chest	  and	  providing	   a	   defibrillating	   countershock	   applied	   directly	   to	   the	   heart.	   This	   idea	  evolved	   into	   the	   development	   of	   external	   defibrillation;	   reports	   of	   successful	  defibrillation	   using	   an	   external	   alternating	   current	   shock	   were	   first	   published	   in	  1956.	   [12]	   In	  1962,	  another	  advance	  was	  made	  when	  a	  research	  group	   found	  that	  direct	   current	   shocks	   to	   the	   heart	  were	   effective	   and	  much	   safer	   than	   alternating	  current	  shocks,	  which	  often	  lead	  to	  arrhythmia	  and	  mortality.	  [11]	  Throughout	  the	  early	  1960’s,	  research	  on	  direct	  current	  defibrillation	  proved	  its	  safety	  and	  efficacy.	  	  As	  a	   result,	   external	  defibrillation	  quickly	  became	  known	  as	  an	  effective	  means	   to	  terminate	  ventricular	  fibrillation.	  	  History	  and	  Development	  of	  the	  Implantable	  Cardioverter	  Defibrillator	  By	  the	  1960’s,	  it	  had	  long	  been	  recognized	  that	  ventricular	  fibrillation	  caused	  a	   large	  proportion	  of	  out	  of	  hospital	  sudden	  cardiac	  death.	   	  With	  the	  advent	  of	  the	  external	  defibrillator,	  patients	  suffering	  from	  ventricular	  fibrillation	  in	  the	  hospital	  could	   be	   promptly	   saved.	   	   However,	   most	   people	   who	   developed	   sudden	   cardiac	  arrest	   did	   so	   outside	   the	   hospital.	   In	   the	   late	   1960’s,	   Dr.	   Michel	   Mirowski	   began	  working	   on	   an	   implantable	   device	   that	   could	   potentially	   prevent	   these	   out	   of	  hospital	   sudden	   cardiac	   deaths	   by	   sensing	   ventricular	   fibrillation	   and	   promptly	  delivering	  a	  shock	  to	  abort	  the	  arrhythmia.	  	  	  Dr.	   Mirowski	   and	   his	   collaborators	   tested	   the	   prototype	   of	   an	   implantable	  defibrillating	   device	   in	   dogs	   with	   great	   success,	   leading	   to	   the	   publication	   of	   a	  landmark	   paper	   in	   1970	   detailing	   the	   initial	   design	   and	   application	   of	   the	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“automatic	  defibrillator”	   in	  dogs.	   [13]	  This	  work	  attracted	  the	  attention	  of	  Medrad	  Inc.,	  a	  medical	  device	  company.	   	  Over	  the	  next	  decade,	  Dr.	  Mirowski	  and	  a	  team	  at	  Medrad	  continued	  to	  refine	  the	  defibrillator	  until	  they	  achieved	  a	  model	  that	  could	  be	  chronically	  implanted	  and	  was	  suitable	  in	  size	  to	  be	  used	  with	  a	  human.	  The	  team	  successfully	  implanted	  this	  improved	  device	  in	  dogs,	  and	  Dr.	  Mirowski	  published	  the	  results	  of	   the	   long-­‐term	  dog	  studies	  and	  the	  design	  of	   this	  updated	  defibrillator	   in	  1978.	   	  After	  more	  extensive	  testing	  and	  development,	  the	  implantable	  defibrillator	  was	  first	  implanted	  in	  a	  human	  in	  1980.	  [14]	  This	  early	  model	  of	   the	   implantable	  defibrillator	  weighed	  half	   a	  pound	  and	  comprised	   electrodes	   protruding	   from	   a	   hermetically	   sealed	   box	   containing	   the	  defibrillator	   (Figure	   3).	   	   Thoracotomy	   was	   required	   for	   placement	   of	   the	   two	  electrodes,	  which	  were	  attached	  to	  heart	  via	  epicardial	  patches.	  	  All	  the	  materials	  in	  the	  defibrillator	  were	  chosen	  to	  be	  compatible	  with	  human	  tissues.	  	  This	  model	  also	  improved	  several	  parameters	  of	  the	  previous	  automatic	  defibrillator,	   including	  the	  sensing	   mechanism.	   	   Ventricular	   fibrillation	   was	   identified	   by	   the	   absence	   of	   an	  isoelectric	   segment	   in	   the	   cardiac	   cycle,	   a	  more	  direct	  measure	   than	   the	   pressure	  changes	  measured	  in	  the	  prototype.	  	  Also	  improved	  in	  the	  new	  model	  was	  the	  shock	  delivery	   mechanism,	   which	   allowed	   for	   up	   to	   4	   shocks	   to	   be	   delivered	   after	   the	  onset	  of	  an	  arrhythmia.	  [15]	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Figure	  3.	  A	  figure	  excerpted	  from	  Mirowsky's	  1978	  paper,	  showing	  a	  photo	  of	  
the	  implantable	  cardioverter-­‐defibrillator.	  [15]
	  	  After	   the	   success	   of	   the	   initial	   human	   implantations,	   Medrad	   sponsored	  further	  clinical	  trials	  of	  the	  device.	  [16]	  These	  clinical	  trials	  culminated	  in	  1985,	  with	  the	  United	  States	  Food	  and	  Drug	  Administration	  (FDA)	  approval	  of	  the	  use	  of	  ICDs	  for	   secondary	  prevention	  of	   sudden	   cardiac	  death	   in	  patients	  who	  had	  a	  previous	  sudden	  cardiac	  arrest	  and	   in	  patients	  who	  had	  ventricular	  arrhythmias	   that	   could	  not	  be	  medically	  suppressed.	  	  	  [17]	  Since	  the	  initial	  FDA	  approval	  of	  the	  ICD,	  the	  device	  has	  undergone	  numerous	  improvements.	   	   The	   generator	   became	   smaller,	   with	   modern	   versions	   weighing	  about	   3	   ounces	   (Figure	  4).	   	   This	   size	   reduction	   allowed	   for	   implantation	  over	   the	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chest	   instead	  of	  over	  the	  abdomen.	   	  Lead	  technology	  also	  improved,	   leading	  to	  the	  first	   completely	   transvenous	   lead	  placement	   in	   1988.	   	   This	   system	   involved	   leads	  with	  shocking	  coils	  that	  attached	  to	  the	  myocardium	  (Figure	  5).	  	  Sensing	  technology	  progressed,	   leading	   to	   drastically	   reduced	   incidence	   of	   inappropriate	   shocks.	  	  Finally,	   defibrillating	   technology	   improved.	   Especially	   important	   was	   the	   1993	  development	  of	  the	  biphasic	  defibrillation	  waveform,	  which	  lowered	  the	  amount	  of	  energy	  necessary	   to	  defibrillate	  an	  arrhythmia	  and	  reduced	  the	  risk	  of	  myocardial	  injury	  from	  the	  shock.	  	  The	  above	  improvements	  helped	  make	  ICDs	  more	  acceptable	  to	   patients	   and	   played	   a	   part	   in	   the	   acceptance	   of	   wider	   indications	   for	   ICDs.	  	  Indeed,	   ICDs	   are	   implanted	   today	   in	   routine,	   minimally	   invasive	   procedures,	   and	  they	   are	   indicated	   for	   prevention	   of	   sudden	   cardiac	   death	   from	   a	  wide	   variety	   of	  conditions.	  [16,	  18]	  
Figure	  4.	  A	  photo	  of	  a	  modern	  implantable	  cardioverter-­‐defibrillator.
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Figure	  5.	  ICD	  with	  transvenous	  lead	  placement.
	  
ICDs	  for	  Secondary	  Prevention	  	   ICDs	   were	   first	   used	   for	   secondary	   prevention,	   the	   prevention	   of	   sudden	  cardiac	   death	   in	   people	  who	   have	   a	   history	   of	   previous	   sudden	   cardiac	   arrest	   or	  underlying	  heart	  disease	  with	  sustained	  ventricular	  tachycardia.	  	   The	   evidence	   supporting	   ICDs	   in	   secondary	   prevention	   came	   from	   three	  large	  randomized	  controlled	  trials	  from	  the	  1990s,	  the	  AVID,	  CASH,	  and	  CIDS	  studies	  (Figure	  6).	  	  The	  largest	  of	  these	  trials,	  AVID,	  was	  a	  randomized	  trial	  comparing	  ICD	  to	  antiarrhythmic	  therapy	  in	  1,016	  patients	  with	  either	  prior	  sudden	  cardiac	  arrest	  or	  sustained	  ventricular	  tachycardia	  and	  ejection	  fraction<40%.	  ICDs	  were	  found	  to	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reduce	  mortality	  by	  31%	  compared	  to	  antiarrhythmics	  at	  three	  years	  of	  follow	  up.	  [19]	  	  
Figure	  6.	  Randomized	  clinical	  trials	  of	  ICDs	  for	  secondary	  prevention	  [18]	  
	  








AVID* 1016$ Prior$SCA,$VT$with$syncope,$or$VT$with$EF<40%$ ICD$vs$antiAarrhythmic$ ICDs$decrease$mortality$by$31%$at$3$years$
CASH* 288$ Prior$SCA$ ICD$vs$antiAarrhythmic$ ICDs$decrease$mortality$by$28%$at$3$years$







MADIT* 196$ $ $ $
CABG*Patch* 900$ $ $ $
MUSTT* 704$ $ $ $
MADIT*II* 1232$ $ $ $
CAT* 104$ $ $ $$ $ $ $ $$ $ $ $ $$
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Figure	  7.	  Randomized	  clinical	  trials	  of	  ICDs	  for	  primary	  prevention.	  [21]
	  









MADIT* 196$ Prior$MI$with$EF<35%,$NSVT,$and$inducible$VT$on$EPS$ ICD$vs$medical$therapy$ ICD$decreases$mortality$
CABG*
Patch*
900$ CABG$with$EF<36%$and$+signalNavg$EKG$ ICD$vs$control$ No$benefit$to$ICD$
MUSTT* 704$ Prior$MI$with$EF<40%,$NSVT,$and$inducible$VT$ EPS$guided$therapy$with$ICD$or$meds$vs$no$therapy$ ICD$decreases$mortality$
MADIT*II* 1232$ Prior$MI,$EF<30%$ ICD$vs$medical$therapy$ ICD$decreases$mortality$
SCDDHeFT* 2521$ NYHA$Class$II$or$III$HF$with$EF<35%$ ICD$vs$amiodarone$vs$placebo$ ICD$decreases$mortality$
IRIS* 898$ Recent$MI$(within$31$days)$and$EF<40$with$HR>90$or$NSVT$ ICD$vs$medical$therapy$ No$benefit$to$ICD$
DINAMIT* 674$ Recent$MI$(within$40$days),$EF<35%,$and$low$HRV$or$high$RHR$$ ICD$vs$control$ No$benefit$to$ICD$
DEFINITE* 458$ DCM,$EF<35%,$and$VPB$or$NSVT$ ICD+medical$therapy$vs$medical$therapy$$ Trend$for$ICD$to$decrease$mortality$
CAT* 104$ DCM$with$EF<30%$ ICD$vs$control$ No$benefit$to$ICD$
AMIOVIRT* 103$ DCM$with$EF<35$and$NSVT$ ICD+amiodarone$vs$amiodarone$$ No$benefit$to$ICD$CABG=coronary$artery$bypass$grafting;$DCM=dilated$cardiomyopathy;$EF=ejection$fraction;$EPS=electrophysiology$study;$HF=heart$failure;$RHR=resting$heart$rate;$HRV=heart$rate$variability;$MI=myocardial$infarction;$NSVT=nonNsustained$ventricular$tachycardia;$NYHA=New$York$Heart$Association;$VPB=ventricular$premature$beat;$VT=ventricular$tachycardia$
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immediate	  post-­‐MI	  implantation	  does	  not	  improve	  survival	  and	  play	  a	  large	  part	  in	  why	   immediate	   post-­‐MI	   implantation	   is	   not	   recommended	   today.	   	   Another	   large	  study,	   CABG-­‐Patch,	   found	   that	   ICD	   implantation	   at	   the	   time	  of	   bypass	   surgery	  did	  not	  improve	  survival.	  	  ICDs	  have	  also	  been	  shown	   to	  be	  useful	   in	  both	  non-­‐ischemic	  and	   ischemic	  heart	   failure.	   	   Published	   in	  2005,	   SCD-­‐HeFT	  was	   a	   randomized	   trial	   of	   2,521	  New	  York	   Heart	   Association	   (NYHA)	   Class	   II	   or	   Class	   III	   heart	   failure	   patients	   with	  ejection	  fraction	  less	  than	  35%.	  	  The	  patients	  in	  this	  study	  all	  received	  conventional	  medical	   therapy	   and	   were	   randomized	   to	   receive	   one	   of	   three	   additional	  treatments:	   amiodarone,	   ICD,	   or	   placebo.	   	   This	   study	   found	   that	   ICD	   decreased	  mortality	  by	  23%	  compared	  to	  placebo	  and	  was	  effective	  in	  both	  ischemic	  and	  non-­‐ischemic	  heart	  failure.	  	  Amiodarone	  did	  not	  decrease	  mortality.	  [22,	  23]	  As	  a	  result	  of	  SCD-­‐HeFT,	  indications	  for	  ICD	  were	  widened	  to	  include	  patients	  with	  heart	  failure	  with	  ejection	  fraction	  less	  than	  35%.	  	  Current	  Guidelines	  for	  Implantable	  Cardioverter	  Defibrillators	  The	   indications	   for	   ICD	   have	   rapidly	   expanded	   in	   the	   past	   15	   years.	   	   As	   a	  result,	   ICD	   implantation	   has	   increased	   dramatically	   as	   well.	   	   Today,	   there	   are	  hundreds	   of	   thousands	   of	   people	   in	   the	   United	   States	   living	   with	   ICDs,	   with	  approximately	  150,000	  patients	  receiving	  ICDs	  each	  year.	  [24]	  ICDs	  are	  indicated	  as	  first-­‐line	  treatment	  in	  many	  heart	  conditions.	  The	  2008	  American	  College	  of	  Cardiology/American	  Heart	  Association/Heart	  Rhythm	  Society	  joint	   guidelines	   outlined	   the	   current	   indications	   for	   ICD	   implantation.	   	   Per	   the	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guidelines,	  ICDs	  should	  be	  used	  for	  secondary	  prevention	  of	  sudden	  cardiac	  death	  in	  patients	   who	   have	   suffered	   a	   previous	   episode	   of	   sudden	   cardiac	   arrest	   with	   no	  identifiable	  reversible	  cause	  and	  in	  patients	  with	  episodes	  of	  sustained	  ventricular	  tachycardia	  with	   underlying	   heart	   disease.	   ICDs	   should	   be	   implanted	   for	   primary	  prevention	  in	  patients	  with	  a	  history	  of	  myocardial	  infarction	  and	  a	  left	  ventricular	  ejection	  fraction	  of	  less	  than	  30%.	  	  ICDs	  should	  also	  be	  used	  for	  primary	  prevention	  in	   patients	   with	   ischemic	   or	   nonischemic	   cardiomyopathy,	   with	   a	   left	   ventricular	  ejection	   fraction	  of	   less	   than	  35%	  NYHA	  Class	   II	   or	   III	  heart	   failure.	   [25]	   ICDs	  are	  also	  implanted	  for	  primary	  prevention	  in	  certain	  patients	  with	  genetic	  or	  idiopathic	  heart	   conditions	   predisposing	   to	   ventricular	   tachycardia/fibrillation,	   such	   as	  Brugada	   syndrome,	   long	   QT	   syndrome,	   hypertrophic	   cardiomyopathy,	   or	  arrhythmogenic	  right	  ventricular	  cardiomyopathy.	  [25]	  	  Remote	  Monitor	  Background	  	   Remote	  monitors,	   first	   introduced	   to	   the	  market	   in	   2002,	   are	   devices	   that	  enable	   ICD	   patients	   to	   follow	   up	   and	   diagnosis	   problems	   from	   home.	   	   Remote	  monitors	   gather	   information	   like	   heart	   rhythms,	   lead	   performance,	   shocks	  delivered,	  and	  battery	  life	  from	  patients’	  ICDs	  and	  send	  it	  over	  a	  standard	  telephone	  line	  to	  a	  server	  that	  physicians	  can	  access	  via	  a	  secure	  website	  (Figure	  8).	  	  All	  ICDs	  today	  are	  compatible	  with	  remote	  monitoring	  systems.	  [26,	  27]	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Figure	  8.	  Schematic	  of	  wireless	  remote	  monitor	  transmission.
	  
Overview	  of	  Remote	  Monitors	  Recommendations	  	   There	  is	  significant	  evidence	  that	  remote	  monitoring	  has	  benefits	  in	  terms	  of	  survival,	   hospitalization,	   safety,	   cost,	   and	   ease	   of	   use.	   In	   light	   of	   the	   available	  evidence,	   both	   the	   2009	   Heart	   Rhythm	   Society/American	   College	   of	   Cardiology	  (ACC)/American	   Heart	   Association	   (AHA)	   and	   the	   2012	   European	   Heart	   Rhythm	  Association	   (EHRA)/Heart	   Rhythm	   Society	   (HRS)	   task	   forces	   released	   consensus	  guidelines	   that	   recognize	   the	   benefits	   of	   remote	   monitoring	   and	   acknowledge	  remote	   monitors	   as	   an	   appropriate	   choice	   for	   post-­‐ICD	   implantation	   follow	   up.	  [28],[29]	   The	   available	   evidence	   has	   led	   the	   2013	   Canadian	   Cardiovascular	  Society/Canadian	   Heart	   Rhythm	   Society	   task	   force	   to	   go	   one	   step	   further	   and	  recommend	  the	  universal	  use	  of	  remote	  monitors	  as	  a	  part	  of	  standard	  care	  of	  ICD	  patients.	  [30]	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Remote	  Monitors	  May	  Improve	  Survival	  	   The	   most	   compelling	   argument	   for	   remote	   monitor	   usage	   is	   the	   survival	  benefit	  associated	  with	  their	  use.	   	  The	  survival	  benefit	   is	  best	  demonstrated	  in	  the	  ALTITUDE	  Survival	  Study.	  	  This	  study,	  the	  largest	  of	  its	  kind,	  examines	  survival	  in	  a	  prospective	  cohort	  of	  185,778	  patients	  up	   to	   five	  years	  after	   ICD	   implantation.	   	   In	  the	  cohort,	  69,556	  patients	  used	  a	  remote	  monitor	  and	  116222	  patients	  did	  not.	  	  At	  five	  years	  from	  implantation,	  the	  patients	  using	  remote	  monitors	  had	  a	  50%	  relative	  reduction	  in	  the	  risk	  of	  death	  (p<0.0001)	  compared	  to	  the	  patients	  being	  followed	  in	  clinic	   only.	   	   This	   survival	   benefit	   persisted	   even	   after	   adjusting	   for	   age,	   gender,	  device	  type,	  and	  year	  of	  implantation.	  	  [31]	  	   This	   survival	  benefit	   is	   likely	  due	   to	  earlier	  detection	  of	  events	   that	   lead	   to	  faster	  diagnosis	   and	   treatment.	   	  Also,	   patients	  may	  be	  more	  motivated	   to	  manage	  their	  health	  after	  making	  transmissions	  with	  the	  monitor.	  [31]	  One	  limitation	  of	  the	  ALTITUDE	  study	  is	  that	  it	  is	  not	  randomized.	  Because	  of	  this,	   it	   is	   possible	   that	   the	   survival	   benefit	   seen	   in	   remote	   monitor	   users	   is	   a	  reflection	  of	   the	  “healthy-­‐adherer	  effect.”	   [32]	  Another	   limitation	  of	   the	  ALTITUDE	  study	  is	  a	  lack	  of	  detailed	  clinical	  information	  about	  the	  patients,	  which	  could	  lead	  to	  confounding.	   	   However,	   the	   authors	   demonstrated	   that	   patients	   using	   standard	  follow	  up	  would	  have	   to	  have	  5	   times	  more	  baseline	   risk	   factors	   than	   the	   remote	  monitoring	  group	  to	  be	  able	  to	  account	  for	  the	  difference	  in	  mortality.	  	  [31]	  Overall,	   the	   ALTITUDE	   study	   provides	   good	   evidence	   that	   there	   is	   likely	   a	  survival	   benefit	   to	   using	   remote	   monitors,	   and	   there	   are	   currently	   randomized	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controlled	  trials	  underway	  to	  determine	  the	  effect	  of	  remote	  monitors	  on	  survival.	  [33,	  34]	  	  Other	  Health-­‐Related	  Benefits	  of	  Remote	  Monitors	  Survival	  is	  not	  the	  only	  benefit	  of	  remote	  monitors.	  	  One	  study	  demonstrating	  the	  safety	  and	  faster	  recognition	  of	  clinical	  events	  provided	  by	  remote	  monitoring	  is	  the	   Lumos-­‐T	   Safely	   Reduces	   Routine	   Office	   Device	   Follow-­‐Up	   (TRUST)	   Trial,	   a	  randomized	  study	  of	  1,339	  patients	  comparing	  remote	  follow	  up	  to	  standard	  follow	  up.	   	  The	  remote	   follow	  up	  group	  had	  continuous	  remote	  monitoring	  with	   in	  office	  visits	  at	  3	  and	  15	  months	  post-­‐ICD,	  whereas	  the	  standard	  follow	  up	  group	  had	  office	  visits	   every	   3	   months	   post-­‐ICD.	   	   At	   one	   year	   post-­‐implantation,	   there	   was	   no	  difference	   in	   morbidity	   between	   the	   two	   groups.	   	   In	   addition,	   the	   number	   of	   in-­‐hospital	   device	   evaluations	  was	   reduced	   by	   45%	   in	   the	   remote	  monitoring	   group	  because	  the	  vast	  majority	  of	  follow	  up	  could	  be	  completed	  with	  the	  remote	  monitor.	  	  Finally,	  this	  study	  strikingly	  found	  that	  the	  time	  elapsed	  between	  onset	  of	  a	  clinically	  significant	   arrhythmia	   (atrial	   fibrillation,	   ventricular	   tachycardia,	   or	   ventricular	  fibrillation)	  and	  evaluation	  by	  a	  physician	  was	  significantly	  reduced	  from	  an	  average	  of	   36	   days	   in	   the	   standard	   follow	   up	   group	   to	   less	   than	   two	   days	   in	   the	   remote	  monitoring	  group.	  [35]	  Another	   study	   that	   demonstrates	   the	   safety	   and	   reduction	   of	   shocks	  administered	  associated	  with	  remote	  monitoring	  is	  the	  ECOST	  trial,	  a	  study	  of	  433	  ICD	   patients	   who	  were	   randomized	   1:1	   to	   either	   remote	   follow	   up	   or	   outpatient	  follow	  up.	  	  Over	  a	  24.2-­‐month	  follow	  up	  period,	  38.5%	  of	  remote	  follow	  up	  patients	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and	   41.5%	   of	   standard	   follow	   up	   patients	   experienced	   a	   major	   adverse	   event,	  defined	   as	   death	   or	   a	  major	   cardiovascular	   event.	   	   This	   rate	  was	   not	   significantly	  different	  between	   the	   two	  groups.	   	   Interestingly,	   the	  ECOST	   study	  also	   found	   that	  the	   remote	   follow	   up	   group	   received	   71%	   fewer	   appropriate	   and	   inappropriate	  shocks	   than	   the	   standard	   follow	  up	   group.	   	   The	   reduced	  number	   of	   shocks	   in	   the	  remote	   group	  was	   likely	   due	   to	   early	   recognition	   and	   treatment	   of	   inappropriate	  shocks	   and	   by	   prevention	   of	   appropriate	   shocks	   with	   early	   implementation	   of	  antiarrhythmic	  treatments.	  [36]	  Remote	   monitoring	   may	   also	   decrease	   the	   length	   of	   hospital	   stay	   after	   a	  cardiovascular	   event.	   	   The	   “Clinical	   Evaluation	   of	   Remote	   Notification	   to	   Reduce	  Time	  to	  Clinical	  Decision	  (CONNECT)”	  study	  is	  a	  randomized	  trial	  of	  1,997	  patients	  examining	  the	  effect	  of	  remote	  monitoring	  on	  response	  time	  to	  a	  clinical	  event.	  	  Like	  the	   TRUST	   trial	   above,	   the	   CONNECT	   trial	   found	   that	   remote	   monitoring	  significantly	  reduced	  the	  time	  from	  clinical	  event	  to	  clinical	  decision,	  from	  22	  days	  in	  the	  standard	  follow	  up	  group	  to	  4.6	  days	  in	  the	  remote	  follow	  up	  group	  (p<0.001).	  	  Importantly,	   this	   faster	   response	   time	   seems	   to	   be	   clinically	   meaningful;	   the	  remotely	   monitored	   group	   had	   a	   shorter	   length	   of	   stay	   for	   cardiovascular	  hospitalizations,	  3.3	  days	  versus	  the	  control	  group’s	  4.0	  days	  (p=0.002).	  [37]	  Due	  to	  the	  TRUST,	  ECOST,	  and	  CONNECT	  trials,	  as	  well	  as	  several	  other	  trials,	  remote	  monitors	  are	  now	  generally	  recognized	  as	  being	  a	  safe	  alternative	  to	  office	  visits.	   	   As	   a	   result,	   many	   centers,	   including	   Yale’s,	   have	   implemented	   remote	  monitoring	  follow	  up	  schedules	  that	  can	  replace	  office	  visits.	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Remote	  Monitors	  are	  Cost	  Effective	  Remote	   monitors	   have	   been	   shown	   to	   reduce	   healthcare	   costs.	   The	  CONNECT	  trial,	  discussed	  above,	  found	  that	  the	  reduction	  in	  length	  of	  hospital	  stay	  lead	  to	  a	  savings	  of	  $1,793	  per	  cardiovascular	  hospital	  stay.	  	  [37]	  Remote	  monitors	  may	  also	  reduce	  costs	  by	  reducing	  the	  number	  of	  in-­‐office	  visits.	  	  This	  makes	  sense	  because	  as	  described	  above,	  patients	  can	  be	  safely	  followed	  with	  fewer	  in-­‐office	  visits	  if	  they	  are	  using	  a	  remote	  monitor.	  	  One	  prospective	  study	  of	  41	  patients	  being	  followed	  with	  remote	  monitors	  found	  that	  substitution	  of	  two	  in-­‐office	  visits	  with	  remote	  monitoring	  over	  the	  9-­‐month	  follow	  up	  period	  reduced	  the	  cost	  of	  ICD	  follow	  up	  by	  a	  average	  of	  524	  euros	  per	  patient,	  a	  cost	  reduction	  of	  41%.	   	  This	  reduction	   in	  cost	  was	  due	   to	  several	   factors,	   including	   lower	  physician	  evaluation	   cost	   for	   remote	   transmissions,	   avoidance	   of	   travelling	   costs	   for	   the	  patient,	  and	  decreased	  need	  for	  taking	  sick	  days	  for	  in-­‐office	  visits.	  [38]	  	  Remote	  Monitors	  are	  Easy	  to	  Use	  	   Several	   small	   studies	   have	   found	   that	   both	   patients	   and	   doctors	   have	   high	  levels	  of	  satisfaction	  with	  remote	  monitors.	  	  In	  one	  prospective	  study	  of	  41	  patients	  using	  remote	  monitors,	  94%	  of	  patients	  felt	  that	  overall,	  the	  remote	  monitor	  either	  met	   or	   exceeded	   their	   expectations.	   	   Almost	   all	   patients	   in	   this	   study	   found	   the	  monitor	   easy	   to	   set	   up	   and	   use.	   	   This	   study	   also	   examined	   physicians’	   thoughts	  about	  the	  remote	  monitoring	  system.	   	  Notably,	   it	   found	  that	  97%	  of	   transmissions	  were	  either	  ‘easy’	  or	  ‘very	  easy’	  to	  access	  by	  physicians.	  [38]	  A	  more	  recent	  survey	  of	   288	   remote	  monitoring	   patients	   reinforced	   that	   remote	  monitors	  were	   easy	   to	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use	  by	  both	  patients	  and	  physicians	  and	  in	  addition	  showed	  that	  half	  of	  patients	  felt	  that	  remote	  monitor	  usage	  led	  to	  improved	  communication	  with	  their	  doctor.	  [39]	  	  Details	  of	  Remote	  Monitor	  Usage	  
	   Remote	  monitors	  remain	  plugged	  into	  a	  power	  source	  and	  landline	  phone	  jack.	  	  The	  monitor	  is	  compatible	  with	  most	  landlines,	  but	  sometimes	  a	  phone	  adaptor	  is	  needed.	  	  If	  patients	  do	  not	  have	  access	  to	  a	  landline,	  cellular	  adapters	  that	  allow	  transmission	  through	  a	  company-­‐issued	  device	  can	  be	  rented	  for	  a	  monthly	  fee	  of	  between	  $10	  and	  $20.	  Remote	  monitors	  come	  packaged	  with	  written	  instructions	  and	  a	  DVD	  explaining	  the	  set	  up	  and	  usage	  of	  the	  monitor.	  	  The	  monitor	  has	  lights	  that	  indicate	  the	  status	  of	  the	  monitor	  (Figure	  9).	  	  It	  also	  has	  toggle	  buttons	  (Figure	  10)	  that	  allow	  the	  user	  to	  configure	  the	  monitor	  to	  the	  specific	  type	  of	  phone	  line	  (tone	  versus	  pulse)	  and	  to	  add	  a	  prefix	  number	  for	  phone	  lines	  that	  require	  it	  to	  dial	  out.	  	  
Figure	  9.	  Explanation	  of	  the	  lights	  on	  the	  remote	  monitor.	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Figure	  10.	  Diagrams	  of	  the	  toggle	  buttons	  on	  the	  remote	  monitor.
	  	  
Remote	  monitors	  can	  be	  either	  manual	  or	  wireless.	  	  Manual	  monitors	  require	  the	  patient	  to	  place	  a	  sensor	  over	  their	  ICD	  and	  press	  a	  button	  to	  manually	  initiate	  the	   interrogation.	  Wireless	  monitors	   can	   continuously	   interrogate	   a	   patient’s	   ICD	  without	  any	  action	  by	  the	  patient,	  after	  an	  initial	  set	  up.	  	  A	  patient	  needs	  to	  be	  within	  about	  a	  10-­‐foot	  radius	  of	  the	  automatic	  monitor	   in	  order	  for	  the	  monitor	  to	  detect	  the	  patient’s	  ICD,	  so	  most	  patients	  choose	  to	  place	  the	  monitor	  in	  the	  bedroom.	  	  [40]	  	  Remote	  Monitor	  Usage	  is	  Low	  	   Despite	  the	  survival	  benefit,	  safety,	  cost	  effectiveness,	  and	  ease	  of	  use	  of	   remote	  monitors,	   many	   people	   still	   do	   not	   use	   remote	  monitors.	   	   Institutional	  data	  from	  Yale	  shows	  that	  about	  54%	  of	  patients	  who	  receive	  a	  Medtronic	  ICD	  and	  are	  eligible	  to	  receive	  a	  remote	  monitor	  actually	  choose	  to	  sign	  up	  for	  the	  monitor.	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Of	  the	  patients	  who	  receive	  the	  monitor,	  roughly	  80%	  use	  the	  monitor	  consistently.	  	  This	  leads	  to	  an	  overall	  remote	  monitor	  usage	  rate	  of	  only	  43%.	  Co-­‐author	   Dr.	   Lynda	   Rosenfeld	   has	   conducted	   studies	   now	   in	   press	   that	  indicate	   that	   21%	  of	   people	  who	  have	  Medtronic	   remote	  monitors	   nationwide	  do	  not	   use	   them.	   	   Female	   gender,	   age	   less	   than	   40,	   smaller	   clinics,	   and	   certain	  geographic	   areas	   (the	   Medicare	   Census	   Mountain	   Region)	   were	   found	   to	   predict	  non-­‐transmission.	   	  This	  study	  recommended	  further	  research	   in	  these	  populations	  in	  order	  to	  develop	  strategies	  to	  improve	  monitor	  usage.	  [41]	  	   In	  addition,	  a	  recent,	   large	  prospective	  cohort	  study	  of	  40,000	  patients	   that	  analyzed	   data	   from	   in	   the	   National	   Cardiovascular	   Data	   Registry	   (NCDR)	   ICD	  Registry	   and	   from	   Boston	   Scientific,	   an	   ICD	   manufacturer,	   has	   also	   shown	   that	  remote	  monitors	  are	  used	  in	  only	  47%	  of	  eligible	  patients.	  	  This	  low	  usage	  was	  due	  to	  a	  combination	  of	  not	  signing	  up	  for	  the	  monitor	  and	  not	  using	  the	  monitor	  once	  signed	  up.	  	  The	  authors	  suggest	  further	  study	  on	  how	  the	  elucidated	  factors	  relate	  to	  enrollment	  and	  activation	  of	  the	  monitor.	  [42]	  Despite	  interest	  in	  the	  reasons	  that	  people	  do	  not	  use	  remote	  monitors,	  there	  is	  a	  dearth	  of	  data	  in	  the	  literature	  about	  the	  reasons	  people	  do	  not	  transmit.	  	  These	  reasons	  need	  to	  be	  elucidated	  so	  that	  remote	  monitor	  usage	  can	  be	  increased.	  	  	  	  
II.	  Aims	  The	   aims	   of	   this	   study	   are	   two-­‐fold.	   	   First,	   quantitative	   factors	   that	   may	   affect	  remote	  monitor	  usage	  will	  be	  examined	   for	  correlations	  with	  monitor	  usage.	   	   It	   is	  hypothesized	   that	   increased	   age,	   lower	   socio-­‐economic	   status,	   government	   health	  
	   21	  
insurance,	  lack	  of	  a	  landline,	  lower	  technology	  usage,	  and	  increased	  disease	  severity	  will	  correlate	  with	  non-­‐usage.	  	  Second,	  qualitative	  methods	  will	  be	  used	  to	  generate	  hypotheses	  about	  patient-­‐centered	  factors	  that	  impact	  remote	  monitor	  usage.	  	  
III.	  Methods	  Mixed	  Methods	  Convergent	   parallel	   mixed-­‐methods,	   meaning	   concurrent	   collection	   and	  analysis	   of	   qualitative	   and	   quantitative	   data,	   were	   used	   in	   this	   study.	   [43]	  Quantitative	  data	  can	  elicit	  relationships	  between	  factors	  known	  to	  affect	  access	  and	  usage	   of	   healthcare	   and	   remote	   monitor	   usage.	   	   Qualitative	   data	   can	   be	   used	   to	  generate	  theories	  about	  the	  barriers	   to	  remote	  monitoring.	   	  The	  two	  types	  of	  data	  compliment	  each	  other	  and	  can	  be	  used	  to	  gain	  a	  more	  thorough	  understanding	  of	  factors	  that	  affect	  the	  usage	  of	  remote	  monitors.	  The	  qualitative	  portion	  of	  this	  study	  was	  based	  on	  the	  principles	  of	  grounded	  theory.	   	   Grounded	   theory,	   first	   introduced	   by	   Glauser	   and	   Strauss	   in	   1967,	   is	   a	  method	  of	  generating	  theories	  based	  on	  observations.	  	  In	  this	  method,	  the	  process	  of	  data	  gathering	  is	  open	  and	  iterative.	  No	  preconceived	  notions	  are	  brought	  into	  the	  study,	  and	  questions	  are	  designed	  to	  be	  open-­‐ended	  to	  generate	  theories.	  	  As	  data	  is	  collected,	   patients’	   responses	   are	   continuously	   analyzed	   to	   generate	   tentative	  theories	  that	  are	   flexible	  and	  can	  be	  refined	  with	   further	  data	  collection.	   	  Through	  this	   analysis,	   general	   themes	   emerge.	   	   Data	   collection	   continues	   until	   there	   is	  thematic	   saturation,	   defined	   as	   the	   cessation	   of	   emergence	   of	   new	   themes	   with	  subsequent	  interviews.	  [44]	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  Patient	  Selection	  Patients	  who	  received	  a	  Medtronic	   ICD	  compatible	  with	  remote	  monitoring	  at	   Yale	   Electrophysiology	   or	   at	   the	   Cardiology	   Associates	   of	   New	  Haven	   between	  January	  2007	  and	  June	  2012	  were	  eligible	  to	  participate	  in	  this	  study.	  	  Patients	  who	  did	   not	   speak	   English,	   were	   under	   the	   age	   of	   18,	   or	   did	   not	   have	   capacity	   were	  excluded.	  A	   list	   of	   patients	   meeting	   the	   inclusion	   criteria	   was	   generated	   from	   a	  Medtronic	  database.	  	  The	  patients	  were	  divided	  into	  three	  groups	  as	  defined	  below:	  	  	  1. “Transmitters”-­‐	   patients	   who	   were	   enrolled	   in	   Medtronic’s	   remote	  monitoring	   system,	   Carelink,	   and	   had	   made	   at	   least	   2	   transmissions	   with	  their	  monitor	  over	  the	  past	  year.	  	  	  2. “Non-­‐transmitters”-­‐	   patients	  who	  were	   enrolled	   in	   Carelink,	   and	  had	  made	  one	  or	  zero	  transmissions	  with	  their	  monitor	  over	  the	  past	  year.	  3. “Not	  enrolled”-­‐	  patients	  who	  were	  not	  enrolled	  in	  Carelink	  and	  thus	  did	  not	  have	  a	  remote	  monitor.	  Medical	  record	  review	  was	  then	  performed	  to	  identify	  each	  patient’s	  address	  and	   telephone	   number.	   	   Also,	   information	   such	   as	   birthdate,	   gender,	   date	   of	   ICD	  implantation,	  and	  ICD	  serial	  number	  was	  collected	  from	  patients’	  charts.	  	  	  	  Patient	  Recruitment	  Recruitment	   letters	   describing	   the	   study	   and	   notifying	   patients	   of	   their	  eligibility	   to	  participate	  were	  sent,	   starting	  with	   those	  patients	  who	  received	   their	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ICD	  most	  recently	  and	  proceeding	  in	  backward	  chronological	  order.	   	  Patients	  were	  informed	   that	   study	   personnel	   would	   be	   contacting	   them	   and	   were	   given	   the	  opportunity	  to	  “opt-­‐out”	  of	  the	  study	  by	  leaving	  a	  message	  at	  a	  phone	  number	  given	  in	  the	  letter.	  	  Patients	  who	  left	  a	  message	  were	  not	  contacted.	  	  Attempts	  were	  then	  made	   to	  contact	   the	  remaining	  patients	  by	   telephone.	   	  Patients	  were	  contacted	  by	  phone	  and	  asked	  if	  they	  wanted	  to	  participate.	  	  Those	  who	  chose	  to	  participate	  were	  consented	  over	  the	  phone.	  	  Patients	   were	   offered	   compensation	   for	   their	   participation	   in	   this	   study.	  “Non-­‐Transmitters”	  and	  “Not	  Enrolled”	  patients	  were	  offered	  $60	  for	  participation,	  and	  “Transmitter”	  patients	  were	  offered	  $25	  for	  participation.	  In	  the	  non-­‐transmitters	  group,	  169	  recruitment	  letters	  were	  sent,	  51	  patients	  were	   reached	  by	   telephone,	   and	  27	   agreed	   to	  participate	   in	   the	   study.	   	   In	   the	  not	  enrolled	   group,	   132	   recruitment	   letters	   were	   sent,	   59	   patients	   were	   reached	   by	  telephone,	  and	  29	  agreed	  to	  participate	  in	  the	  study.	  	  In	  the	  transmitters	  group,	  105	  recruitment	   letters	   were	   sent,	   45	   patients	   were	   reached	   by	   telephone,	   and	   26	  agreed	  to	  participate	   in	   the	  study.	   	  Of	  note,	  patients	  were	  sometimes	  misclassified	  initially;	   transmission	   status	   was	   reassigned	   in	   these	   patients	   after	   patient	  interview.	  	  (Figure	  11)	  Overall,	  82	  patients	  participated	  in	  this	  study.	  	  The	  participants	  comprised	  28	  non-­‐transmitters,	   36	   transmitters,	   and	   18	   not	   enrolled	   patients.	   	   One	   transmitter	  and	   one	   non-­‐transmitter	   completed	   only	   the	   qualitative	   section	   of	   the	   interview,	  citing	  time	  limitations	  and	  difficulty	  hearing,	  respectively.	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Figure	  11.	  Enrollment	  data	  for	  not	  enrolled,	  transmitter	  and	  non-­‐transmitter	  
groups.
	  
	  	  Quantitative	  Methods	  All	  quantitative	  questions	  were	  administered	  over	  the	  telephone	  by	  E.L.,	  and	  data	  was	   entered	   in	   an	   Excel	   spreadsheet,	   in	   real	   time.	   	   Patients’	   responses	  were	  also	  recorded	  so	  that	  data	  could	  be	  reviewed	  for	  accuracy.	  The	   quantitative	   section	   of	   this	   study	   was	   designed	   to	   gather	   data	   about	  factors	  that	  may	  influence	  remote	  monitor	  usage.	  	  Factors	  that	  typically	  affect	  access	  and	  usage	  of	  healthcare,	  such	  as	  age,	  gender,	  and	  socioeconomic	  status	  (household	  size,	   occupation	   and	   education	   level	   [45])	   were	   collected.	   	   Patients’	   occupations	  were	  classified	  into	  one	  of	  two	  groups,	  manual/clerical	  or	  professional/managerial	  based	  on	  Hollingshead	  criteria	  [45].	   	  In	  addition,	  the	  Yale	  electrophysiology	  nurses	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were	   consulted	   about	   the	   types	   of	   issues	   they	   thought	   affected	   remote	   monitor	  usage.	  These	  factors	  included	  type	  of	  phone	  service,	  whether	  the	  phone	  service	  was	  bundled,	  and	   the	   type	  of	  health	   insurance	  coverage.	   	  The	  quantitative	  section	  also	  included	  the	  Brief	  Illness	  Perception	  Questionnaire.	  	  	  Quantitative	  Data-­‐	  The	  Brief	  Illness	  Perception	  Questionnaire	  The	   Brief	   Illness	   Perception	   Questionnaire	   is	   a	   9-­‐question	   instrument	   that	  probes	  a	  patient’s	  ideas	  about	  his	  or	  her	  illness	  (Figure	  ).	   	  There	  are	  8	  LIkert-­‐scale	  questions,	  each	  about	  how	  a	  patient	  feels	  about	  a	  facet	  of	  their	  disease.	  	  There	  is	  also	  one	  free	  response	  question	  about	  why	  the	  patient	  thinks	  they	  have	  developed	  their	  disease.	  	  The	  free	  response	  answers	  in	  the	  Brief	  Perception	  of	  Illness	  Questionnaire	  were	  coded	  into	  two	  different	  categories	  for	  analysis:	  controllable	  factors,	   like	  diet	  or	  smoking,	  and	  uncontrollable	  factors,	  like	  genetics.	  
Figure	  12.	  	  The	  items	  of	  the	  brief	  perception	  of	  illness	  questionnaire.
	  
!!
Theme%Probed% Question%Consequences! How!much!does!your!illness!affect!your!life?!Timeline! How!long!do!you!think!your!illness!will!continue?!Personal!control! How!much!control!do!you!feel!you!have!over!your!illness?!Treatment!control! How!much!do!you!think!your!treatment!can!help!your!illness?!Identity! How!much!do!you!experience!symptoms!from!your!illness?!Concern! How!concerned!are!you!about!your!illness?!Understanding! How!well!do!you!feel!you!understand!your!illness?!Emotional!representation! How!much!does!your!illness!affect!you!emotionally?!Causation! Please!list!the!three!most!important!factors!that!you!believe!caused!your!illness.!The!first!8!questions!below!are!answered!on!an!11Epoint!Likert!Scale,!from!0E10.!!The!last!question!is!freeEresponse.!
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The	  Brief	  Illness	  Perception	  Questionnaire	  has	  been	  internally	  and	  externally	  validated	  in	  patients	  with	  several	  acute	  and	  chronic	  conditions,	   including	  diabetes,	  asthma,	   colds,	   and	   myocardial	   infarction.	   	   The	   scores	   on	   the	   questionnaire	   have	  been	  shown	  to	  correlate	  with	  outcomes	  in	  several	  conditions	  as	  well.	  [46]	  	  Quantitative	  Data	  Analysis	  Data	   analysis	   was	   completed	   by	   R.L.	   and	   E.L.	   	   An	   Excel	   spreadsheet	  containing	  all	  the	  quantitative	  data	  was	  imported	  into	  JMP	  9	  statistical	  software	  for	  data	   analysis.	   	   ANOVA	   and	   t-­‐test	   were	   used	   to	   compare	   continuous	   variables	  between	  three	  and	  two	  groups,	  respectively.	  	  Post-­‐hoc	  t-­‐test	  analysis	  was	  performed	  when	   ANOVA	   indicated	   significance.	   	   Continuous	   variables	   included	   age,	   means	  household	  size,	  and	  all	  the	  Likert	  scale	  questions	  and	  on	  the	  Brief	  Illness	  Perception	  Questionnaire.	  Categorical	  variables,	   including	  gender,	  education	   level,	  employment	  status,	  health	   insurance	   status,	   telephone	   type,	   computer	   usage,	   and	   the	   coded	   free	  response	   question	   on	   the	   Brief	   Illness	   Perception	   Questionnaire,	   were	   analyzed	  using	   chi-­‐squared	   analysis.	   	   Multivariate	   analysis	   was	   conducted	   to	   control	   for	  variables.	  	  Qualitative	  Methods	  and	  Grounded	  Theory	  	   The	  qualitative	  interview	  was	  designed	  to	  probe	  patients’	  perceptions	  of	  their	  remote	  monitors.	  	  In-­‐depth	  interviews	  were	  conducted	  with	  very	  general	  questions	  exploring	  topics	  such	  as	  patients’	  feelings	  and	  experiences	  with	  their	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remote	  monitors,	  and	  their	  experiences	  with	  other	  aspects	  of	  their	  heart	  disease,	  including	  experiences	  with	  their	  ICD	  and	  with	  managing	  multiple	  conditions.	  	  The	  questions	  were	  designed	  to	  probe	  for	  specific	  barriers	  to	  using	  remote	  monitors	  as	  well	  as	  related	  topics	  such	  as	  patients’	  overall	  attitudes	  toward	  their	  remote	  monitor,	  ICD,	  and	  heart	  disease.	  	  While	  there	  was	  an	  interview	  guide	  for	  the	  overall	  structure	  of	  the	  interview	  (Figure	  13),	  the	  interviewee	  directed	  the	  course	  of	  the	  discussion	  so	  that	  rich	  data	  could	  be	  collected.	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Interview	  Procedure	  	  	   Interviews	   were	   conducted	   over	   the	   telephone.	   	   The	   first	   two	   interviews	  were	   conducted	   by	   K.M.	   while	   being	   observed	   by	   E.L.	   	   	   K.M.	   then	   observed	   E.L.	  conducting	  the	  next	  two	  interviews	  and	  gave	  feedback.	  	  E.L.	  proceeded	  to	  complete	  the	  rest	  of	  the	  interviews.	  	  Interviews	  continued	  until	  thematic	  saturation	  occurred.	  	  The	  conversations	  were	  recorded	  and	  then	  sent	  to	  various	  transcription	  services	  to	  be	  transcribed.	  	  	  	  
	  Qualitative	  Data	  Analysis	  	   The	   interview	   transcriptions	   were	   verified	   for	   accuracy	   of	   content.	   	   All	  members	  of	  the	  research	  team	  (E.L.,	  K.M.,	  R.L.)	  reviewed	  a	  portion	  of	  the	  interviews	  transcriptions	   line	   by	   line.	   	   Each	   team	   member	   independently	   coded	   these	  transcripts	  using	  the	  principles	  of	  grounded	  theory,	  as	  described	  above.	  The	  coding	  was	  reviewed	  jointly	  to	  ensure	  inter-­‐rater	  reliability.	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IV.	  Results	  
Quantitative	  Data	  	   The	  participants	  in	  the	  three	  groups,	  transmitters,	  non-­‐transmitters,	  and	  not	  enrolled,	  did	  not	  differ	  significantly	  in	  gender	  or	  age	  (Table	  14).	  	  






%Male 68% 75% 0.52 
Mean age (S.D.) 65 (16) 69 (14) 0.27 
% with HS diploma 81% 89% 0.43 
% with 4-yr degree 41% 29% 0.32 
% Working 33% 37% 0.76 
Mean household size (S.D.) 2.2 (1.0) 2.5 (1.4) 0.16 
% with manual/clerical jobs 46% 36% 0.47 
% with government health insurance 52% 20% 0.01* 
% with landline 78% 100% 0.003* 
% with bundled phone service 71% 67% 0.72 
% owning computer 74% 86% 0.25 
% using computer at least weekly 48% 76% 0.02* 
Significant	  p-­‐values	  are	  denoted	  with	  a	  “*”.	  	  Socioeconomic	  Status	  Measures	  	   Several	  measures	   of	   socioeconomic	   status	  were	   studied.	   	   Non-­‐transmitters	  had	  a	  significantly	  higher	  number	  of	  patients	  on	  government	  insurance	  (Medicaid	  or	  Medicare	  with	  no	  secondary	   insurance)	   than	  transmitters,	  p=0.01.	   	   Insurance	  type	  remained	   significant	   after	   controlling	   for	   age.	   	   Other	   measures	   of	   socioeconomic	  status,	   including	  education	   level,	  household	   size,	   and	   type	  of	   employment,	  did	  not	  differ	  between	  transmitters	  and	  non-­‐transmitters.	  	  Telephone	  and	  Computer	  Usage	  Results	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   Significantly	   fewer	   non-­‐transmitters	   owned	   a	   landline	   compared	   to	  transmitters,	  78%	  versus	  100%,	  p=0.003.	  	  Non-­‐transmitters	  were	  also	  significantly	  less	  likely	  to	  use	  a	  computer	  than	  transmitters;	  48%	  of	  non-­‐transmitters	  and	  78%	  of	  transmitters	   used	   a	   computer	   at	   least	   once	   a	   week,	   p=0.02.	   	   There	   was	   a	   non-­‐statistically	   significant	   trend	   for	   non-­‐transmitters	   to	   be	   less	   likely	   to	   own	   a	  computer.	  	  	  Brief	  Illness	  Perception	  Results	  	  
Table	  15:	  Brief	  Illness	  Perception	  Questionnaire	  results	  
  Non-transmitters Transmitters Not Enrolled p-value 
Consequences 5.7 (3.2) 5.4 (3.7) 4.8 (3.4) 0.73 
Timeline 9.2 (2.2) 9.4 (1.9) 9.4 (1.9) 0.86 
Personal Control 6.6 (3.0) 5.9 (3.6) 4.5 (3.6) 0.14 
Treatment Control - ICD 8.5 (2.5) 8.9 (1.8) 9.2 (1.4) 0.57 
Treatment Control - Monitor *6.5 (3.4) *8.9 (1.7) 7.9 (3.3) 0.005** 
Identity 3.9 (3.4) 2.7 (3.1) 2.3 (2.2) 0.18 
Concern 6.4 (3.4) 5.0 (3.8) 3.9 (3.3) 0.07 
Understanding 8.6 (2.4) 8.6 (2.2) 8.7 (1.7) 0.97 
Emotional Response 5.5 (3.6) 4.5 (3.9) 4.9 (3.5) 0.60 
Total Score 41.2 (13) 34.8 (14.7) 34.5 (10.9) 0.19 
This	  table	  shows	  the	  mean	  response	  and	  standard	  deviation	  for	  each	  item	  in	  the	  Brief	  Illness	  
Perception	  Questionnaire.	  P-­‐values	  less	  than	  0.05	  are	  denoted	  with	  “**”.	  	  	  	  Pairs	  of	  values	  
determined	  to	  differ	  significantly	  with	  paired	  t-­‐test	  post	  hoc	  analysis	  are	  denoted	  with	  “*”.	  	   The	  only	  significant	  difference	  between	  the	  three	  groups	  in	  the	  Brief	  Illness	  Perception	  Questionnaire	  (Table	  15)	  was	  in	  the	  “Treatment	  Control-­‐Monitor”	  item.	  	  In	   this	   question,	   transmitters	   found	   the	   remote	   monitor	   to	   be	   significantly	   more	  beneficial	  than	  the	  non-­‐transmitters,	  with	  respective	  average	  helpfulness	  ratings	  of	  8.9	  and	  6.5,	  p=0.005.	  There	  was	   a	  non-­‐significant	   trend	   for	  non-­‐transmitters	   and	   transmitters	   to	  be	   more	   concerned	   about	   their	   heart	   conditions	   compared	   to	   the	   not	   enrolled	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group,	   p=0.07.	   	   Post	   hoc	   analysis	   showed	   the	   largest	   difference	  between	   the	  non-­‐transmitter	  and	  not	  enrolled	  groups,	  p=0.01.	  	  Other	   results	   that	   approached	   significance	   included	   a	   trend	   for	   non-­‐transmitters	  and	  transmitters	  to	  believe	  they	  had	  more	  control	  over	  their	  condition	  (in	  the	  “Personal	  Control”	  item)	  than	  the	  not	  enrolled	  patients	  and	  a	  trend	  for	  non-­‐transmitters	   to	   have	   more	   symptoms	   (in	   the	   “Identity”	   item)	   from	   their	   heart	  condition	  than	  transmitters	  or	  not	  enrolled	  patients.	  	  Based	  on	  the	  cumulative	  score,	  there	  was	  a	  non-­‐significant	  trend	  for	  non-­‐transmitters	  to	  view	  their	  disease	  as	  more	  threatening	  than	  transmitters	  or	  not	  enrolled	  patients.	  	  	  In	   the	   free	   response	   question,	   54%	   of	   transmitters	   and	   67%	   of	   non-­‐transmitters	  listed	  at	  least	  one	  controllable	  cause	  for	  their	  heart	  disease,	  p=0.32.	  	  
Qualitative	  Data	  
Experiences	  with	  Health	  The	   first	   domain	   queried	   during	   in-­‐depth	   interviews	   was	   patients’	  experiences	   with	   their	   health,	   including	   experiences	   with	   heart	   disease,	   multiple	  conditions,	  and	  ICDs	  Experiences	  with	  Heart	  Disease	  Both	   transmitters	   and	   non-­‐transmitters	   seemed	   to	   have	   similar	   sets	   of	  experiences	   with	   their	   heart	   disease.	   	   In	   both	   groups,	   negative	   themes	   such	   as	  limitations,	   difficult	   illness,	   and	   fear	   emerged.	   	   One	   transmitter	   said	   of	   his	   heart	  condition:	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“Oh,	  it’s	  horrible,	  let’s	  put	  it	  that	  way.	  I	  worry	  about	  doing	  things	  I	  probably	  shouldn’t	  do.	  I	  don’t	  want	  to	  get	  over-­‐worked.	  I	  pretty	  much	  got	  away	  from	  a	  lot	  of	  my	  outdoor	  activities.	  A	  lot	  of	  walking,	  I	  don’t	  do	  anymore.”	  	  	  A	  non-­‐transmitter	  noted	  the	  limitations	  of	  his	  heart	  condition:	  ”There’s	  a	  lot	  of	  things	  I	  can’t	  do	  that	  I	  used	  to	  do.”	  Many	  positive	  themes,	  such	  as	  uncomplicated	  disease	  and	  easy	  management,	  emerged	   in	   all	   three	   groups.	   	   One	   transmitter	   noted	   the	   minimal	   impact	   of	   his	  disease:	  	  “It's	   been	   good,	   it	   hasn't	   been	   bad,	   at	   all.	   	   [I]	   just	   go	   about	   my	   normal	  activities.”	  	  	  A	  non-­‐transmitter	  had	  a	  similarly	  positive	  experience	  with	  his	  heart	  condition:	  	  “I	   do	   the	   regular	   things	   around	   the	   house.	   [My	   heart	   condition]	   doesn’t	  bother	  me	  a	  bit.”	  	  	  One	  not	  enrolled	  patient	  said	  of	  his	  heart	  condition:	  “It	  just	  has	  become	  a	  way	  of	  life.	  I	  think	  I	  adapted	  fairly	  well.	  It's	  not	  difficult	  to	  eat	  right	  and	  exercise.	  That's	  part	  of	  my	  regime,	  now.	  I	  don't	  feel	   like	  it's	  any	  type	  of	  handicap	  or	  anything	  like	  that.”	  Of	   note,	   the	   not	   enrolled	   patients	   tended	   to	   have	  more	   positive	   experiences	  with	  their	  heart	  conditions	  compared	  to	  the	  transmitters	  and	  non-­‐transmitters.	  	  Experiences	  with	  Multiple	  Conditions	  Patients	   in	   all	   three	   groups	   had	   similar	   comorbidities,	   with	   diabetes,	   back	  conditions,	   lung	  disease,	  hypertension,	   and	  kidney	  disease	   commonly	  occurring	   in	  all	  three	  groups.	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   Management	  of	   the	  multiple	   conditions	  was	  also	   similar	  between	   the	   three	  groups,	  with	  all	  three	  groups	  citing	  diet	  and	  other	  lifestyle	  changes	  as	  management	  strategies.	   	   Of	   note,	   the	   non-­‐transmitters	   seemed	   to	   use	   more	   mobility	   aids,	   like	  canes,	  walkers,	  or	  wheelchairs.	  	  	  	   Despite	   the	   similarities	   in	   types	   and	   management	   of	   comorbidities,	   non-­‐transmitting	   patients	   seemed	   to	   have	   a	   slightly	  more	   negative	   overall	   experience	  with	  their	  multiple	  conditions	  compared	  to	  the	  two	  other	  groups.	  	  Though	  all	  three	  groups	  had	  mixed	  experiences	  with	   comorbidities,	  more	  negative	   themes,	   such	  as	  difficult	   management,	   symptoms,	   and	   confusion,	   occurred	   in	   the	   non-­‐transmitter	  group.	   	   	   One	   non-­‐transmitter	   expressed	   the	   difficulty	   of	   managing	   multiple	  conditions:	  “I've	   had	   some	   difficulty	   with	   my	   lungs…	   And	   then	   from	   the	   radiation	   I	  developed	  some	  gastrointestinal	  problems…	  [The	  heart	  condition	  is]	  just	  one	  more	   thing,	   you	  know?	   It	   just	   adds	   to	   it	   all.	  Cumulatively,	   it	   kind	  of	   gets	   to	  you,	  you	  know?”	   	  Experiences	  with	  ICD	  Patients	   in	   all	   three	   groups	   were	   able	   to	   appreciate	   the	   benefits	   of	   ICDs,	  citing	  the	  ICD’s	  ability	  to	  save	  lives	  and	  the	  sense	  of	  security	  the	  device	  offered.	  	  For	  example,	  a	  patient	  said:	  “So,	  it's	  also	  a	  comfort	  to	  know	  that	  I	  don't	  have	  to	  worry.	  	  It’s	  just	  been	  like	  having	  an	  insurance	  policy	  on	  you.”	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All	   three	   groups	   also	   had	   similar	   ranges	   of	   experiences	  with	   their	   ICDs.	   	   A	  large	  number	  of	  patients	  in	  all	  three	  groups	  found	  their	  ICDs	  to	  be	  unobtrusive	  and	  easy	  to	  manage.	  A	  patient	  voiced	  this	  sentiment:	  “I	  don’t	  worry	  much	  about	  [my	  ICD],	  it’s	  just	  there.	  	  It	  doesn’t	  seem	  to	  require	  management	  on	  my	  part.”	  There	   were	   also	   patients	   in	   each	   of	   the	   three	   groups	   that	   had	   negative	  experiences	  with	  the	  ICD.	  	  Some	  patients	  were	  scared	  of	  the	  defibrillator	  firing:	  	  “It’s	  scary,	  	   the	  defibrillator	  firing	  and	  knocking	  you	  on	  your	  butt.	  It’s	   just	  always	  on	  my	  mind,	   like	  worrying	  about	  getting	  a	  cold	   if	  you	  go	  outside,	  or	  something.“	  	  Other	  patients	  had	  experiences	  with	  recalled	  leads:	  “The	  first	  one	  I	  had	  was	  …	  defective.	  So,	   it	  was	  shocking	  me.	  So	  they	  had	  to	  take	  that	  one	  out	  of	  me.”	  
	   Despite	  largely	  positive	  experiences,	  many	  patients	  in	  all	  three	  groups	  were	  able	  to	  identify	  minor	  disadvantages	  of	  the	  ICD,	  such	  as	  aesthetic	  faults	  and	  minor	  discomfort.	   Many	   patients	   noted	   the	   protrusion	   of	   the	   device	   and	   the	   scar	   from	  implantation:	  “I	  don’t	  really	  like	  [the	  ICD]	  totally,	  because	  you	  can	  see	  it	  through	  my	  skin,	  the	  lump.”	  	  	  	  “I	  was	  aware	  of	  wearing	  low	  scoop-­‐neck	  shirts,	  because	  you	  see	  the	  scar.”	  	  	  Some	  patients	  had	  discomfort	  during	  driving	  or	  sleeping:	  “I	  think	  the	  only	  negative	  I	  can	  say	  about	  the	  defibrillator	  is	  that	  when	  I	  wear	  a	  seatbelt,	  it's	  very	  uncomfortable.”	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“I	  have	  one	  minor	  problem	  with	  [the	  ICD].	  If	  I	   lie	  on	  my	  right	  side	  in	  bed	  at	  night,	  the	  pacemaker	  throbs	  a	  little	  bit,	  which	  keeps	  me	  awake.	  So,	  I	  have	  to	  sleep	  on	  my	  left	  side.”	  	  	  
	  
Experiences	  with	  Remote	  Monitors	  	   The	   next	   domain	   queried	   during	   the	   in-­‐depth	   interview	   was	   patients’	  experiences	  with	   their	   remote	  monitors.	   	  This	   included	   thoughts	  about	  benefits	  of	  monitors,	   experiences	   with	   setup	   and	   usage	   of	   monitors,	   and	   other	   factors	  influencing	  transmission.	  Transmitters	  Identify	  More	  Benefits	  to	  Monitor	  Usage	  Transmitters	  were	  better	  able	  to	  identify	  the	  benefits	  of	  the	  remote	  monitor	  compared	   to	  non-­‐transmitters	  and	  not	  enrolled	  patients.	  Many	   transmitters	  noted	  the	  ability	  of	  the	  monitor	  to	  diagnose	  problems:	  “[The	   remote	   monitor]	   picks	   up	   things	   that	   you	   don't	   even	   realize	   are	  happening.	  Some	  of	  the	  times	  that	  my	  heart	  got	  out	  of	  rhythm	  there,	  I	  didn't	  even	  know	  it.	   	   [The	  doctor’s	  office]	  called	  me	  to	  come	   in	   there	  and	  shock	   it	  back	  into	  rhythm	  again.	  	  	  Some	  transmitters	  also	  recognized	  that	  monitors	  led	  to	  more	  prompt	  evaluation	  of	  problems:	  “If	   I	  have	  an	  episode,	   then	  the	  doctor	  can	   just	   tell	  me	  to	  go	  ahead	  and	  send	  him	  the	   information	  rather	   than	  wait	   to	  go	   to	   the	  office	  and	  get	   it	   checked.	  It's	  just	  a	  lot	  more	  convenient,	  and	  a	  lot	  quicker.”	  Many	  transmitters	  also	  noted	  that	  the	  monitor	  gave	  them	  a	  sense	  of	  security:	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  “[The	   remote	   monitor]	   gives	   you	   a	   feeling	   of	   comfortableness	   in	   that	  somebody's	  looking	  at	  it	  to	  make	  sure	  things	  are	  working	  alright.”	  Many	  transmitters	  also	  appreciated	  that	  remote	  monitors	  reduced	  clinic	  visits:	  “It's	   a	   great	   benefit.	   You	   don't	   have	   to	   see	   the	   doctor	   as	   often	   because	   it's	  transmitted.	  	  Yes,	  and	  it	  helps	  me	  as	  far	  as	  transportation.”	  	  In	   contrast	   to	   transmitters,	   non-­‐transmitters	   tended	   to	   identify	   the	  secondary	  benefits	  of	  the	  monitor,	  such	  as	  convenience	  and	  reduced	  clinic	  visits:	  The	  non-­‐transmitters	  tended	  to	  not	  recognize	  the	  primary	  benefits	  of	  the	  monitor,	  namely	  improved	  diagnosis	  and	  evaluation	  of	  events.	  Not	  enrolled	  patients	  were	  generally	  not	  familiar	  with	  any	  of	  the	  benefits	  of	  the	  remote	  monitor.	  	  Some	  not	  enrolled	  patients	  did	  not	  know	  whether	  there	  were	  benefits	   to	   the	  monitor,	   and	   others	   believed	   that	   there	  was	   no	   reason	   to	   use	   the	  remote	  monitor:	  	  “I	   really	   don't	   think	   it's	   going	   to	   help	  me	   at	   all	   because	  when	   I	   go	   to	   [my	  doctor]	  every	  3rd	  month	  and	  all	   they	  say	   is,	   "You're	  doing	  fine	  and	  nothing	  happened,"	   I'd	  be	   carrying	   that	   goddamn	   thing	  around	   for	  nothing.	   I'm	  not	  going	  to	  do	  that.”	  Reasons	  for	  Not	  Enrolling	  in	  Carelink	  Patients	  who	  chose	  to	  not	  enroll	   in	  Carelink	  cited	  three	  major	  categories	  of	  reasons:	  	  1. Remote	  monitor	  not	  offered.	  2. Perceived	  lack	  of	  benefit	  to	  the	  monitor	  3. Lack	  of	  a	  landline.	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Each	  category	  is	  discussed	  below.	  -­‐Remote	  Monitor	  Not	  Offered	  Many	  of	  the	  not	  enrolled	  patients	  were	  never	  presented	  with	  the	  option	  of	  a	  remote	  monitor.	  	  For	  example,	  two	  patients	  shared	  their	  experiences:	  “No	  one's	  ever	  talked	  about	  a	  monitor	  with	  me.”	  	  “I	  don't	  think	  [the	  remote	  monitor]	  has	  ever	  been	  offered	  to	  me.	  I	  don't	  know	  if	  they	  ever	  had	  a	  program	  through	  my	  doctors	  that	  offered	  [the	  monitor].	  	  I	  was	  not	  even	  aware	  of	  [the	  monitor]	  until	  you	  mentioned	  it.”	  	  	  -­‐Lack	  of	  Benefit	  of	  Remote	  Monitor	  As	  described	  above,	  many	  not	  enrolled	  patients	  did	  not	  believe	  there	  was	  a	  benefit	  to	  using	  a	  remote	  monitor.	  	  One	  patient	  stated:	  “The	  only	  thing	  [the	  remote	  monitor]	  really	  accomplished	  was	  to	  download	  what	  was	   in	  my	  chest.	  So,	   I	   thought	   that	  was	   its	  primary	   function,	  and	   that	  gets	  done	  at	  the	  doctor's	  office,	  so	  it	  didn't	  matter.”	  	  	  Other	  patients	  did	  not	  see	  a	  remote	  monitor	  as	  something	  necessary.	  	  For	  example,	  one	  patient	  said:	  “I	  have	  not	  had	  a	  need	  for	  one,	  but	  if	  I	  felt	  I	  needed	  one	  I	  would	  get	  one.”	  -­‐Lack	  of	  a	  Landline	  	   Finally,	   some	   patients	   who	   did	   not	   enroll	   in	   Carelink	   cited	   the	   lack	   of	   a	  landline.	  	  For	  example,	  one	  patient	  said:	  	  “I	  didn't	  have	  a	  home	  phone	  line.	  	  I	  wanted	  to	  be	  able	  to	  use	  the	  monitor.”	  Another	  patient	  said:	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“I	  don't	  have	  a	   telephone	   line	   for	   [the	  doctor]	   to	  do	   [remote	  monitoring].	   I	  don't	  have	  a	  phone	  because	  I	  don't	  have	  a	  need	  for	  it.	  I	  discontinued	  it	  a	  while	  back.	  	  It	  was	  a	  waste	  of	  money.”	  Reasons	  for	  Not	  Transmitting	  in	  Carelink	  Patients	  had	  diverse	  reasons	  for	  not	  transmitting	  in	  Carelink.	  	  There	  were	  six	  major	  categories	  of	  reasons	  that	  patients	  did	  not	  transmit:	  1. Belief	  that	  transmissions	  were	  actually	  being	  sent.	  2. Problems	  with	  set	  up.	  3. Problems	  with	  phone	  line.	  4. Financial	  barriers.	  5. Low	  strength	  of	  recommendation	  from	  physicians.	  6. Belief	  that	  transmissions	  were	  not	  necessary	  when	  feeling	  well.	  Each	  category	  is	  discussed	  below.	  -­‐Belief	  that	  Transmissions	  are	  Actually	  Being	  Sent	  Some	   non-­‐transmitting	   patients	   mistakenly	   thought	   that	   they	   were	  transmitting.	   	   For	   example,	   one	   non-­‐transmitter	   from	  whom	  no	   transmission	   had	  ever	  been	  received	  described	  his	  experiences	  with	  his	  monitor:	  “It's	  really	  been	  pretty	  easy.	  You	  know,	  the	   instructions	  were	  good.	   I	  would	  just	  go	  into	  my	  bedroom	  and	  close	  the	  door,	  and,	  you	  know,	  do	  what	  it	  said	  and	  it	  was	  very	  simple.”	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-­‐Problems	  with	  Set	  Up	  of	  Monitor	  	  Many	  non-­‐transmitting	  patients	  cited	  difficulty	   in	  the	  set	  up	  of	  the	  monitor.	  	  Some	   patients	   did	   not	   understand	   how	   to	   set	   up	   the	  monitor.	   	   For	   example,	   one	  patient	  said:	  	  “I	  tried	  to	  hook	  it	  up,	  but	  I	  had	  problems	  with	  hooking	  it	  up,	  like	  not	  knowing	  how	  to	  hook	  it	  up.	  Nobody	  ever	  taught	  me	  how	  to	  hook	  it	  up.”	  	  	  Another	  patient	  said:	  “I've	  had	  trouble	  setting	  it	  up.	  Yeah,	  the	  directions	  were	  not	  very	  clear.”	  	  Other	   patients	   found	   the	   set	   up	   difficult	   because	   of	   physical	   limitations.	   	   For	  example,	  one	  elderly,	  frail	  patient	  said:	  	  “They	  gave	  me	  a	  new	  [remote	  monitor].	  Where	  the	  jack	  is	  located,	  behind	  my	  bed,	  I	  can’t	  put	  it	  back	  there.”	  In	   contrast,	   transmitters	   almost	   universally	   believed	   that	   remote	  monitors	  were	  easy	  to	  set	  up.	  One	  transmitter	  said:	  	  “Piece	  of	  cake.	  [The	  set	  up]	  was	  so	  easy,	  it	  wasn't	  funny.”	  	  	  Of	  note,	  despite	  differences	  in	  perceived	  difficulty	  of	  set	  up,	  both	  transmitters	  and	   non-­‐transmitters	   learned	   how	   to	   set	   up	   the	   remote	  monitor	   in	   similar	  ways.	  	  Patients	   in	   both	   groups	   referenced	   the	   Medtronic	   pamphlet	   and	   what	   they	   were	  taught	  by	  their	  doctors.	  	  Though	   transmitters	   and	   non-­‐transmitters	   had	   differing	   experiences	   with	  the	   set	   up	   of	   the	   monitor,	   both	   groups	   overwhelmingly	   believed	   that	   remote	  monitors	  were	  easy	  to	  use	  once	  set	  up.	  	  	  	  For	  example,	  one	  transmitter	  said:	  “I	  think	  [the	  monitor]	  is	  easy	  to	  use.”	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A	  non-­‐transmitter	  had	  a	  similar	  sentiment:	  “[The	  monitor’s]	  pretty	  easy	  to	  use	  and	  there’s	  no	  effort	  at	  all	  on	  my	  part.”	  -­‐Problems	  with	  Phone	  Line	  Another	  common	  cause	  of	  technical	  difficulty	  was	  problems	  with	  the	  phone	  line.	   Some	   non-­‐transmitters	   also	   did	   not	   transmit	   because	   they	   did	   not	   have	  landlines.	  	  For	  example,	  one	  non-­‐transmitter	  said:	  “I	  don’t	  use	  the	  remote	  monitor	  because	  all	   I	  have	  is	  a	  cell	  phone.	   	  And,	  I’m	  surprised	  that	  in	  this	  day	  of	  technology,	  there	  isn’t	  a	  technology	  that	  allows	  me	  to	  use	  that	  monitor	  with	  my	  cell	  phone.”	  	  Several	   patients	   also	   noted	   that	   their	   landlines	   were	   not	   compatible	   with	   the	  monitor.	  	  For	  example,	  one	  patient	  said:	  	  “The	  only	  difficulty	  I	  have	  is	  that	  I	  can’t	  send	  my	  report	  because	  my	  system	  is	  a	  digital	  system	  and	  not	  an	  analogue	  system.”	  	  	  Some	  patients	  also	  noted	  that	  they	  did	  not	  have	  phone	  jacks	  in	  the	  bedroom,	  making	  it	  difficult	  to	  use	  automatic	  monitors.	  	  One	  patient	  explained:	  	  “There’s	  no	  phone	   jack	   in	  my	  room	  where	  I	  sleep.	  The	  kitchen	  has	  the	  only	  phone	  jack.”	  -­‐Financial	  Barriers	  Some	  non-­‐transmitter	   patients	   described	   financial	   barriers	   to	   transmitting.	  	  These	   financial	   issues	   included	   the	   cost	   of	   the	   phone	   line	   and	   problems	   with	  insurance	  coverage	  for	  remote	  monitor	  transmissions.	  	  One	  patient	  with	  out	  a	  phone	  line	  explained:	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“I’m	  strictly	  cellular.	  It’s	  a	  convenience.	  I	  don’t	  need	  another	  phone	  and	  don’t	  want	  to	  pay	  another	  $20	  for	  another	  phone.”	  	  	  Another	  patient	  described	  his	  prohibitive	  insurance	  situation:	  	  “I	   belong	   to	   a	   labor	   union	   and	   we’re	   self-­‐funded,	   our	   insurance,	   and	   our	  board	  of	  trustees	  doesn’t	  believe	  that	  that’s	  absolutely	  medically	  necessary	  to	  remote	  monitor.	   They	   consider	   [the	   transmission]	   a	   diagnostic	   charge,	   and	  they	  don’t	  want	  to	  pay	  it.”	  -­‐Low	  Strength	  of	  Recommendation	  from	  Physician	  Several	   non-­‐transmitters	   cited	   the	   strength	   of	   their	   doctor’s	  recommendation	  in	  their	  decision	  to	  not	  use	  the	  remote	  monitor.	  	  One	  patient	  said	  of	  his	  doctors:	  “They	  don’t	  think	  [remote	  monitoring]	  is	  all	  that	  important.	  They	  never	  said	  to	  me	   that	   it’s	   really	   important	   that	   you	   transmit	   this	   on	   time.	   I	   never	  had	  that	   kind	   of	   a	   conversation	   with	   anybody.	   	   The	   level	   of	   the	   conversation	  hasn’t	  dictated	  that	  I	  create	  this	  as	  a	  priority.”	  	  	  Another	  patient	  felt	  that	  his	  doctors	  presented	  the	  remote	  monitor	  as	  optional:	  	  “They	  say,	  "You	  could	  hook	  this	  up"	  but	  they	  didn't	  say	  I	  had	  to.	  If	  the	  doctors	  insisted	  upon	  it,	  I	  would.”	  A	  few	  non-­‐transmitters	  were	  also	  directly	  advised	  to	  stop	  using	  the	  monitor	  by	  their	  doctors.	  	  One	  patient	  who	  was	  told	  by	  her	  doctor	  to	  stop	  transmitting	  said:	  	  “I	   stopped	   using	   [the	   monitor]	   because	   the	   doctor	   said	   no	   problem	   or	  anything,	  said	  don't	  even	  use	  it.	  	  He	  said,	  "Your	  heart	  is	  stronger	  than	  before,	  you	  don't	  have	  to	  use	  it.”	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In	  contrast	  to	  the	  non-­‐transmitters,	  transmitters	  often	  cited	  their	  physician’s	  high	  strength	  of	  recommendation	  in	  their	  decision	  to	  use	  the	  monitor.	  	  For	  example,	  one	  transmitter	  said	  of	  his	  decision	  to	  use	  the	  monitor:	  	  “I	  want	  to	  do	  what	  the	  doctor	  ordered.”	  	  	  One	  former	  non-­‐transmitter	  who	  had	  recently	  decided	  to	  start	  transmitting	  said:	  	  “I	   had	   seen	   [my	  doctor]	   and	   then	   the	  nurses	   started	  questioning	  me	   about	  the	  monitor.	  	  They	  told	  me	  it	  was	  pretty	  easy	  and	  not	  a	  problem	  so	  I	  thought	  I	  better	  get	  cracking	  and	  start	  [transmitting].”	  -­‐Belief	  that	  Transmissions	  are	  Unnecessary	  when	  Feeling	  Well	  Many	   non-­‐transmitters	   also	   believed	   that	   they	   did	   not	   need	   to	   transmit	  because	  they	  were	  feeling	  well.	  	  For	  example,	  one	  non-­‐transmitter	  said:	  “I	  just	  don't	  feel	  like	  I	  have	  to	  [transmit].	  I	  mean,	  if	  I'm	  uncomfortable,	  if	  I	  felt	  there	  was	  something	  that	  had	  to	  be	  monitored,	  I	  would	  probably	  hook	  it	  up.”	  Another	  non-­‐transmitter	  said:	  	  “I’m	   not	   too	   concerned	   about	   [not	   being	   able	   to	   transmit]	   because	   I	   have	  fewer	   events.	   I	   don’t	   have	   an	   urgency	   to	   send	   [transmissions]	   because	  my	  heart	  rhythms	  are	  so	  good	  and	  I	  very	  rarely	  feel	  any	  kind	  of	  palpitation.”	  Transmitters	  Tend	  to	  Troubleshoot	  Problems	  Of	   note,	   transmitters	   also	   commonly	   faced	   problems	   with	   transmission.	  	  Most	   commonly,	   these	   problems	   involved	   the	   phone	   line.	   	   Several	   transmitters	  required	   an	   adaptor	   in	   order	   to	   transmit	   through	   their	   phone	   lines,	   and	   others	  rented	   the	   Medtronic	   cellular	   adapter.	   Some	   transmitters	   also	   faced	   problems	  involving	  the	  toggle	  buttons	  on	  the	  monitor.	  	  For	  example,	  one	  transmitter	  said:	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“When	  I	  dusted	  the	  machine,	  because	   it's	  on	  my	  nightstand,	   I	  hit	  one	  of	   the	  buttons	   in	   the	   back	   that	   set	   it	   into	   a	   different	  mode.	   So,	   they	  went	   to	   do	   a	  download	  and	  it	  didn't	  go	  through.	  So,	  I	  got	  a	   letter,	   I	  called	  them,	  and	  they	  told	  me	  what	  to	  do	  and	  it	  was	  fixed.”	  
	   Many	   transmitters	  were	   able	   to	   troubleshoot	   and	   solve	   problems	   they	   had	  with	   transmission.	   	  Transmitters	  and	  non-­‐transmitters	  were	  both	  able	   to	   list	   their	  doctor’s	  office	  and	  Medtronic	  as	  where	  they	  would	  theoretically	  turn	  to	  for	  help,	  but	  transmitters	  tended	  to	  actually	  seek	  help	  for	  problems.	  	  	  	  	  
Suggested	  Improvements	  to	  Remote	  Monitors	  	   The	   final	   domain	   addressed	   was	   patients’	   desire	   for	   feedback	   from	   the	  monitor	  and	  improvements	  to	  the	  monitor.	  Feedback	  from	  Clinic	  Many	   patients	   in	   both	   the	   transmitters	   and	   non-­‐transmitters	   groups	  expected	  communication	  from	  the	  clinic	  about	  the	  remote	  monitor	  transmissions.	  	  	  	   Many	  patients	  from	  both	  the	  transmitters	  and	  non-­‐transmitters	  groups	  also	  thought	  that	  the	  clinic	  should	  let	  them	  know	  when	  a	  transmission	  was	  received.	  	  For	  example,	  one	  transmitter	  said:	  “[After	  the	  scheduled	  transmission],	  they	  didn't	  call,	  they	  didn't	  do	  anything.	  Even	  with	  the	  [manual	  monitor]	  before,	  when	  I'd	  do	  it	  myself	  once	  a	  month,	  I'd	  get	  a	  letter	  back.”	  	  Another	  non-­‐transmitter	  had	  a	  similar	  experience:	  “I	  never	  received	  a	  call,	  never	  received	  any	  information	  anywhere.”	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Many	  patients	  also	  expected	  that	  the	  clinic	  would	  inform	  them	  if	  something	  were	  wrong	  with	  their	  transmission.	  	  	  For	  example,	  one	  patient	  said:	  	  “The	  doctor's	  office	  call[s]	  me	  if	  there's	  anything	  wrong.	  If	  I	  don't	  hear	  from	  them,	  then,	  everything's	  fine.”	  	  	  Feedback	  from	  Monitor	  Many	  transmitters	  and	  non-­‐transmitters	  also	  noted	  that	  the	  monitor	  did	  not	  give	  feedback	  about	  whether	  transmissions	  had	  completed.	  	  A	  transmitter	  said:	  “You	  know,	  the	  patient	  actually	  doesn't	  know	  if	  [the	  doctor]	  got	  the	  results.”	  	  One	  non-­‐transmitter	  similarly	  noted:	  	  “[The	  monitor]	   never	   gave	  me	   back	   any	   information,	   it	   never,	   like	   told	  me	  what's	  going	  on,	  or	  what	  the	  doctors	  are	  saying.”	  	  	  Desire	  for	  Confirmation	  of	  Transmission	  Given	  that	  many	  patients	  noted	  the	  lack	  of	  feedback	  after	  transmission,	  it	   is	  not	   surprising	   that	   both	   transmitters	   and	   non-­‐transmitters	   almost	   universally	  thought	  that	  it	  would	  be	  useful	  to	  receive	  confirmation	  that	  transmissions	  had	  gone	  through.	  	  For	  example,	  one	  transmitter	  suggested:	  	  “If	  the	  machine	  had	  a	  light	  that	  was	  like	  an	  indicator	  that	  it	  did	  work,	  [that]	  would	  help.”	  	  Access	  to	  Data	  In	  addition	  to	  wanting	  confirmation,	  most	  transmitting	  and	  non-­‐transmitting	  patients	   also	   wanted	   access	   to	   data	   from	   their	   remote	   monitors.	   	   One	   patient	  suggested:	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“It	  would	  be	  great	  to	  know	  what's	  going	  on.	  Even	  if	  it's	  like	  an	  online	  picture.	  Like	  if	  I	  call	  the	  doctor	  and	  he	  says,	  "Hey,	  go	  to	  this	  website."	  And	  you	  will	  see	  what	  I'm	  seeing.	  That	  would	  be	  great.”	  	  	  Another	  patient	  said:	  “I	   want	   to	   know	   everything	   that's	   going	   on.	   Sometimes	   I	   get	   the	   heart	  palpitations,	  and	  it	  goes	  up	  a	  little	  high	  -­‐	  and	  I	  think,	  "Hm,	  what	  was	  I	  doing	  at	  that	  time?”	  All	  smaller	  subset	  of	  both	  groups	  did	  not	  want	  access	  to	  the	  data	  from	  remote	  monitors.	  	  These	  patients	  tended	  to	  feel	  that	  they	  would	  not	  understand	  or	  be	  able	  to	   apply	   the	   information	   from	   the	   remote	   monitor.	   	   For	   example,	   one	   non-­‐transmitter	  said:	  	  “I	  don’t	  think	  I	  need	  to	  see	  it,	  because	  I	  wouldn’t	  know	  what	  I’m	  looking	  at.”	  	  Desire	  for	  Cellular	  Capability	  Many	   patients	   across	   the	   three	   groups	   also	   suggested	   that	   the	  monitor	   be	  improved	  to	  allow	  for	  cellular	  transmission.	  	  For	  example,	  one	  patient	  said:	  	  	  “The	  point	  is	  [the	  remote	  monitor]	  should	  be	  cell	  phone	  capable	  and	  it’s	  not,	  and	  that	  is,	  in	  my	  opinion,	  unacceptable	  and	  a	  disgrace	  that	  it	  isn’t.”	  	  	  Another	  patient	  said:	  	  “Obviously	   if	   it	   was	   wireless	   and	   didn’t	   have	   to	   be	   connected	   to	   a	   phone	  outlet	  it	  could	  go	  anywhere	  …	  that	  would	  make	  it	  easier.”	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V.	  Discussion	  Quantitative	  analysis	  showed	  that	  transmitters	  and	  non-­‐transmitters	  did	  not	  differ	   significantly	   in	   gender,	   age,	   or	   socioeconomic	   status.	   	   Transmitters	   are	  significantly	   more	   likely	   to	   own	   a	   landline,	   use	   computers	   regularly,	   have	   non-­‐government	   health	   insurance,	   and	   believe	   there	   is	   a	   benefit	   to	   using	   the	  monitor.	  Qualitative	  analysis	  revealed	  six	  major	  categories	  of	  reasons	  that	  non-­‐transmitters	  do	  not	  use	  their	  remote	  monitors:	  belief	  that	  transmissions	  are	  actually	  being	  sent,	  problems	   with	   set	   up,	   problems	   with	   telephone	   landline,	   low	   strength	   of	  recommendation	   from	   physicians,	   financial	   barriers,	   and	   the	   belief	   that	  transmissions	   aren’t	   necessary	   when	   feeling	   well.	   	   This	   study	   also	   found	   three	  categories	  of	  reasons	  that	  patients	  do	  not	  enroll	  for	  a	  remote	  monitor,	  including	  no	  knowledge	  of	  remote	  monitors,	  a	  perceived	  lack	  of	  benefit	  to	  remote	  monitors,	  and	  not	  having	  a	  landline	  telephone.	  	  	  There	   are	   very	   few	   studies	   in	   the	   literature	   that	   address	   the	   reasons	   that	  patients	  do	  not	  use	  remote	  monitoring.	  	  A	  recent	  study	  of	  40,000	  ICD	  patients	  listed	  some	  factors	  that	  are	  associated	  with	  remote	  monitor	  usage.	  	  This	  study	  found	  that	  the	   strongest	   determinant	   of	   enrollment	   for	   monitoring	   was	   the	   prior	   rate	   of	  enrollment	  at	  the	  hospital;	   the	  type	  and	  size	  of	  hospital	  did	  not	  make	  a	  difference.	  	  Physician	   associated	   factors,	   such	   as	   being	   electrophysiology	   board	   certified	   and	  having	   a	   history	   of	  more	   ICD	   implantations	   are	   also	   significantly	   associated	  with	  enrollment	   for	   the	   monitor.	   	   Patient	   factors	   such	   as	   older	   age,	   white	   race,	   non-­‐Medicaid	   health	   insurance,	   and	   better	   overall	   health	   were	   associated	   with	   both	  higher	   rates	   of	   enrollment	   and	   transmission.	   	   This	   study	  was	   not	   able	   to	   directly	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collect	  landline	  information,	  but	  the	  authors	  postulated	  that	  availability	  of	  a	  landline	  telephone	  is	  also	  an	  important	  factor	  that	  is	  related	  to	  monitor	  usage.	  [42]	  A	   review	   of	   the	   current	   literature	   also	   reveals	   a	   small	   qualitative	   study	  examining	   the	   experiences	   with	   remote	   monitors	   of	   4	   non-­‐transmitters	   and	   5	  transmitters.	  	  The	  study	  identified	  lack	  of	  understanding	  of	  the	  remote	  monitor	  and	  lack	  of	  phone	  lines	  as	  possible	  reasons	  that	  patients	  do	  not	  transmit.	  [47]	  This	  study	  expands	  the	  knowledge	  base	  of	  possible	  reasons	  that	  patients	  do	  not	  use	  remote	  monitors.	   	  As	  described	  below,	  the	  data	  suggests	  several	  ways	  that	  physicians	  and	  industry	  can	  help	  to	  increase	  usage	  of	  remote	  monitors.	  	  	  	  Patient	  Characteristics	  	   There	  are	  no	  significant	  differences	  in	  the	  age	  or	  gender	  between	  the	  groups.	  	  Prior	   studies	   of	   remote	   monitoring	   have	   found	   significant	   differences	   in	   age	   and	  gender	   between	   transmitters	   and	   non-­‐transmitters;	   in	   this	   study,	   the	   age	   and	  gender	   trend	   in	   the	   directions	   of	   previous	   reports,	   but	   sample	   size	  was	   not	   large	  enough	  to	  achieve	  significance	  in	  these	  measures.	  	  	   This	   study	   found	  no	  significant	  difference	   in	   socioeconomic	   status	  between	  transmitters	   and	   non-­‐transmitters.	   	   It	   is	   commonly	   accepted	   that	   lower	  socioeconomic	  status	  is	  associated	  with	  less	  healthcare	  usage.	  [48]	  In	  this	  case,	  ICD	  implantation	  may	  have	  served	  as	  a	  screen	  for	  patients	  who	  are	  better	  off.	  This	  study	  also	  found	  that	  non-­‐transmitters	  were	  significantly	  more	  likely	  to	  have	  government	  insurance	  than	  transmitters.	  	  This	  finding	  is	  consistent	  with	  Akar	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et	   al’s	   finding	   that	  patients	  with	   commercial	  or	  HMO	   insurance	  are	  more	   likely	   to	  enroll	  and	  transmit	  than	  those	  with	  Medicaid	  or	  Medicare	  [42].	  	  	  	  Recognition	  of	  Benefit	  	  The	  data	   indicates	   that	  patients	  who	  understand	  the	  benefits	  of	   the	  remote	  monitor	  tend	  to	  use	  the	  monitor.	  	  Quantitative	  data	  from	  the	  Brief	  Illness	  Perception	  Questionnaire	   showed	   that	   transmitters	   rated	   the	   benefit	   of	   remote	   monitors	  significantly	  higher	   than	  non-­‐transmitters.	  Transmitters	  were	  also	   able	   to	   identify	  more	   benefits	   to	   remote	   monitoring	   than	   non-­‐transmitters	   and	   not	   enrolled	  patients.	   	   Patients	   in	   the	   latter	   two	   groups	   often	   cited	   a	   lack	   of	   benefit	   in	   their	  decision	  to	  not	  use	  the	  monitor.	  	  It	  is	  generally	  accepted	  that	  perceived	  benefit	  of	  a	  treatment	  is	  a	  predictor	  of	  treatment	  adherence,	  across	  a	  wide	  spectrum	  of	  diseases	  including	  in	  heart	  disease.	  [49-­‐51]	   	  The	  benefit	  of	  treatment	  item	  on	  the	  Illness	  Perception	  Questionnaire	  has	  also	  been	  shown	   to	  be	  associated	  with	   treatment	  adherence	   in	  several	   conditions.	  [52,	  53]	  	  Based	  on	  the	  findings	  on	  this	  study,	  physicians	  can	  affect	  remote	  monitor	  usage	  by	  clearly	  communicating	  the	  benefits	  to	  patients.	  	  Strength	  of	  Doctor’s	  Recommendation	  	  The	   strength	   of	   a	   doctor’s	   recommendation	   to	   use	   remote	   monitoring	  appeared	  to	  be	  associated	  with	  monitor	  usage.	   	  Many	  transmitters	  received	  strong	  recommendations	   to	   use	   the	   monitor,	   whereas	   many	   non-­‐transmitters	   and	   not	  enrolled	   patients	   felt	   that	   their	   physicians	   presented	   the	   monitor	   as	   something	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unimportant	   or	   optional.	   	   These	   findings	   are	   consistent	   with	   findings	   in	   the	  literature	   showing	   that	   doctor’s	   recommendations	   have	   an	   effect	   on	   patients’	  adoption	   of	   telemonitoring.	   [54]	   Physicians	   should	   consider	   explicitly	  recommending	  remote	  monitoring.	  Akar	   et	   al	   previously	   reported	   that	   remote	  monitor	   enrollment	   and	   usage	  varies	  depending	  on	  physician	   specific	   factors	   [42].	   	   This	   variation	  may	  be	  due	   in	  part	  to	  differing	  strengths	  of	  recommendation	  between	  doctors.	  	  It	  would	  be	  useful	  to	   conduct	   further	   study	   on	   physicians’	   beliefs	   about	   recommendation	   of	   remote	  monitoring	  and	  adoption	  of	  remote	  monitoring	  into	  their	  practices.	  A	  perceived	   low	  strength	  of	  recommendation	  could	  also	  be	  due	  to	  a	   lack	  of	  communication	   or	   misunderstanding	   of	   a	   doctor’s	   recommendation.	   	   This	   is	  supported	  by	  several	  studies	  that	  show	  that	  doctors	  and	  patients	  often	  leave	  shared	  encounters	  with	  different	  perceptions	  of	  the	  encounter.	  [55]	  Again,	  further	  research	  into	  physicians’	  perspectives	  can	  help	  clarify	  this	  issue.	  	  Lack	  of	  Transmission	  Confirmation	  	  A	   surprising	   theme	   that	   emerged	   in	   the	   non-­‐transmitters	   was	   that	   some	  patients	   don’t	   realize	   that	   they	   are	   not	   transmitting.	   	   One	   possible	   reason	   that	  patients	   may	   not	   know	   if	   they	   have	   transmitted	   is	   a	   lack	   of	   feedback	   from	   the	  monitor	  and	  clinic	  about	  transmission	  status.	  	  Patients	  in	  both	  the	  transmitters	  and	  non-­‐transmitters	   groups	   noted	   this	   lack	   of	   feedback.	   	   Patients	   almost	   universally	  desired	  some	  sort	  of	  confirmation	  that	  transmissions	  had	  been	  received.	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These	   data	   suggest	   ways	   in	   which	   device	   manufacturers	   can	   improve	  technology	  to	  increase	  usage	  of	  remote	  monitors.	  	  A	  system	  to	  confirm	  transmission,	  such	  as	  a	  clear	  indicator	  on	  the	  monitor	  or	  an	  automated	  confirmation	  call,	  should	  be	  implemented.	  	  Problems	  with	  Phone	  lines	  	  A	  prior	  small	  focus	  group	  study	  reported	  that	  problems	  with	  landlines	  might	  impede	   transmissions.[47]	   This	   study	   also	   found	   that	   patients	   commonly	   had	  problems	   with	   their	   phone	   lines.	   	   Quantitative	   data	   from	   this	   study	   showed	   that	  non-­‐transmitters	   are	   significantly	   less	   likely	   to	   have	   a	   landline	   than	   transmitters.	  Qualitative	  data	   showed	   that	  problems	  with	  phone	   lines	  prevent	  non-­‐transmitters	  from	   using	   their	  monitor	   and	   deter	   not	   enrolled	   patients	   from	   signing	   up	   for	   the	  monitor.	  	  This	  study	  appears	  to	  be	  the	  first	  to	  delineate	  the	  types	  of	  phone	  problems	  that	   patients	   encountered.	   	   Types	   of	   phone	   problems	   encountered	   included:	   no	  access	   to	   a	   landline,	   phone	   line	   incompatibility	   with	   remote	   monitor,	   and	  inconvenient	  location	  of	  phone	  jacks.	  Device	   manufacturers	   have	   already	   recognized	   that	   problems	   with	   phone	  lines	  are	  common.	  	  One	  solution	  that	  manufacturers	  have	  introduced	  is	  the	  wireless	  adaptor.	   	  Though	  this	  seems	  to	  be	  a	  reasonable	  alternative	  to	  obtaining	  a	   landline,	  this	   study	   found	   that	   many	   patients	   do	   not	   own	   a	   landline	   because	   of	   the	   cost.	  	  	  Often	  times,	  patients	  who	  cannot	  afford	  landlines	  find	  the	  contract	  fee	  and	  rental	  fee	  for	  the	  wireless	  adaptor	  to	  be	  prohibitive	  as	  well.	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Previous	  studies	  have	  shown	  that	  under-­‐served	  patients	  are	  very	  willing	   to	  adopt	  technology	  to	  manage	  their	  health,	  if	  given	  the	  financial	  resources	  to	  be	  able	  to	   do	   so.	   [56]	   Remote	   monitors	   have	   been	   shown	   to	   reduce	   overall	   healthcare	  expenditure	   [37],	   [38],	   so	   providing	   financial	   help	   to	   those	   who	   cannot	   afford	   a	  landline	  or	  the	  wireless	  adaptor	  may	  still	  be	  cost	  effective	  in	  the	  long	  run.	  Of	  note,	  most	  patients	  who	  did	  not	  own	  a	  landline	  did	  own	  a	  cell	  phone,	  and	  there	   was	   significant	   patient	   interest	   in	   being	   able	   to	   use	   cell	   phones	   for	  transmission.	  	  In	  a	  day	  and	  time	  where	  cell	  phone	  usage	  is	  drastically	  increasing	  in	  all	  age	  groups	  and	  more	  than	  half	  of	  young	  adults	  only	  use	  cell	  phones	  [57],	  it	  may	  also	   be	   worthwhile	   for	   device	   makers	   to	   develop	   monitors	   compatible	   with	   cell	  phones.	  	  Physical	  limitations	  	  A	   theme	   that	   emerged	   in	   the	   non-­‐transmitters	   was	   physical	   limitations.	  	  Presence	   of	   physical	   limitations	   may	   be	   a	   factor	   that	   prevents	   use	   of	   remote	  monitors,	   as	   some	   non-­‐transmitters	   reported	   having	   physical	   difficulty	   setting	   up	  the	   remote	  monitor.	   	   This	   study	   also	   found	   that	   non-­‐transmitters	   seemed	   to	   be	   a	  group	  that	  had	  more	  physical	  limitations,	  as	  evidenced	  by	  a	  generally	  more	  negative	  experience	   with	   multiple	   conditions	   and	   higher	   usage	   of	   mobility	   aids.	   This	   is	  corroborated	  by	  a	  previous	  study	  has	  shown	  that	  people	  who	  do	  not	  activate	  their	  remote	   monitors	   are	   an	   overall	   sicker	   group	   of	   patients.	   [42]	   Healthcare	  professionals	  should	  be	  cognizant	  that	  complicated	  illness	  and	  limited	  mobility	  can	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affect	   set	   up	   of	   remote	   monitors	   and	   work	   with	   patients	   and	   their	   families	   to	  arrange	  set	  up	  of	  the	  monitor.	  	  Difficult	  Set	  Up	  and	  Computer	  Literacy	  Many	  patients	  did	  not	  transmit	  because	  the	  set	  up	  of	  the	  remote	  monitor	  was	  too	   difficult.	   	   The	   perceived	   difficulty	   of	   set	   up	   may	   be	   related	   to	   an	   overall	  discomfort	   with	   new	   technology.	   	   This	   study	   found	   that	   non-­‐transmitters	   had	   a	  significantly	  lower	  rate	  of	  computer	  usage	  compared	  to	  the	  transmitters.	  Computer	  usage	   has	   been	   shown	   to	   affect	   the	   adoption	   of	   telemedicine,	   as	   illustrated	   by	   a	  study	   that	   showed	   that	   baseline	   computer	   usage	   correlates	   with	   use	   of	   and	  satisfaction	  with	  a	  diabetes	  telemedicine	  program.	  [58]	  While	   the	   healthcare	   system	   cannot	   impact	   a	   patient’s	   comfort	   with	  technology,	  it	  can	  offer	  resources	  to	  patients	  to	  help	  work	  through	  these	  issues.	  	  As	  a	  future	   direction,	   the	   authors	   of	   this	   study	   are	   conducting	   a	   randomized	   study	   to	  determine	  if	  an	  over-­‐the-­‐telephone	  teaching	  session	  can	  help	  patients	  set	  up	  of	  the	  monitor	  	  	  Troubleshooting	  	  	  It	   is	   interesting	   to	   note	   that	   transmitters	   encountered	   many	   of	   the	   same	  barriers	  that	  non-­‐transmitters	  and	  not	  enrolled	  patients	  did,	  but	  they	  were	  able	  to	  overcome	   those	   barriers.	   	   Transmitters	   were	   able	   to	   use	   clinic	   resources	   and	  Medtronic’s	  helpline	  to	  solve	  their	  problems.	   	  This	  suggests	  that	  part	  of	  the	  reason	  people	  transmit	  is	  due	  to	  a	  determination	  to	  do	  so,	  which	  may	  in	  part	  be	  explained	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by	  the	  transmitters’	  greater	  perceived	  benefit	  of	  remote	  monitoring.	  	  There	  may	  also	  be	   differences	   in	   unexamined	  baseline	   patient	   characteristics	   between	   the	   groups	  that	  can	  help	  explain	  this.	  	  	  	  Desire	  for	  Access	  to	  Data	  	   A	  majority	  of	  both	  transmitters	  and	  non-­‐transmitters	  wanted	  access	  to	  their	  remote	   monitor	   data.	   	   Previous	   studies	   have	   shown	   that	   electronic	   feedback	   has	  already	  been	  used	   successfully	   in	   the	  management	  of	   congestive	  heart	   failure	  and	  asthma.	  [59],[60]	  Although	  there	  was	  a	  cost	  to	  implement	  the	  feedback	  mechanism,	  outcomes	  were	   improved	   for	   patients	   receiving	   the	   electronic	   feedback.	   	   Perhaps	  implementing	  a	  way	  for	  remote	  monitor	  users	  to	  get	  feedback	  can	  offer	  incentive	  for	  using	  the	  monitor	  and	  potentially	   improve	  patient	  outcomes	  as	  well.	   	  Pilot	  studies	  should	   be	   considered	   to	   examine	   electronic	   feedback	   for	   remote	   monitoring	  patients.	  	  	  Future	  Directions	  	   The	  hypotheses	   generated	  using	   qualitative	   research	  need	   to	   be	   confirmed	  with	   quantitative	   methods,	   such	   as	   surveys	   in	   large	   populations.	   	   If	   these	  hypotheses	   can	  be	   confirmed,	   they	   can	  guide	   changes	   to	   increase	   remote	  monitor	  usage	  in	  the	  future.	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VI.	  Conclusions	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